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Abstract 
 
Atherosclerosis, as a primary pathophysiologic condition of cardiovascular disease, 
is chronic inflammation. Acute infection is a well-established risk factor causing the 
destabilization of pre-existing atherosclerotic lesions, leading to a dramatic increase 
probability to suffer from myocardial infarction or stroke. However, the nature of the 
underlying processes remains unclear. Of note, epidemiologic studies show that 
endotoxemia results in heightened lesion development as well as the acceleration 
of atheroprogression. Endotoxins are potent activators of circulating immune cells 
including neutrophils, which foster vascular inflammation through expelled 
chromatin, called neutrophils extracellular traps (NETs) (Figure 1).  
 
 
 
Figure 1: Graphical abstract- NETs as a monocyte adhesion scaffold. 
Bacteria and their products as lipopolysaccharide (LPS) activate leukocytes including neutrophils. 
Upon activation, neutrophils are able to release extracellular traps (NETs), which have been shown 
to play a crucial role during atherogenesis. We hypothesize that neutrophil extracellular traps 
facilitate monocyte adhesion, resulting in accelerated atherosclerotic lesion formation under 
endotoxemia conditions. Main figure components from https://smart.servier.com/. 
V 
 
Here we hypothesized a NET-induced acceleration of atherosclerosis during 
infection. We observed increased leukocyte recruitment in a NET-dependent 
manner in hypercholesteremic and endotoxemia Apoe-/- mice, which led to highly 
increased lesion formation. This effect was abolished when the NET-formation was 
inhibited by the pharmacological compound BB Cl-amidine. Specifically, we 
discovered a NET-resident histone H2A driven leukocyte adhesion, which was 
based on charge interaction. These findings provide a new pathophysiological link 
between NET-borne H2A and monocyte adhesion at the site of developing 
atherosclerotic lesions. Targeting NET-formation has been already shown to be a 
promising strategy to limit atherosclerotic lesion formation. However, it’s overall 
inhibition may also lead to insufficient host defense. Therefore, the here newly 
described histone H2A-dependent myeloid cell recruitment to the atherosclerotic 
site helps to develop a more specific myeloid cell adhesion inhibition to 
therapeutically limit atherosclerosis during infection.  
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1. Introduction  
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1.1. The immune system  
 
The survival of all multicellular beings depends on its ability to detect infectious 
pathogens and to induce an appropriate immune response [1]. Traditionally, the 
immune system is divided into the innate and adaptive immune system [2]. 
Evolutionary, the innate immune recognition appears in all multicellular organisms 
and is older than the adaptive immune system [3]. B cells and T cells belong to the 
adaptive immune response, while the innate immune response is built by 
neutrophils, basophils, eosinophils, mast cells, monocytes, and macrophages as 
well as dendritic cells and natural killer cells [2, 4] (Figure 2).  
 
 
 
Figure 2: Overview of the immune system. 
The innate immune system is divided into innate and adaptive immune responses. The innate 
immunity acts as the first line of defense, eliminating pathogens. It consists of neutrophils, basophils, 
eosinophils, monocytes, macrophages, mast cells, and natural killer cells. B cells and CD4/CD8 
positive T cells belong to the adaptive immune response. The cytotoxic natural killer T cells are in 
the interface of the innate and adaptive immune response. Figure adapted from Dranoff, G. 2004 [4]. 
Main figure components from https://smart.servier.com/. 
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The innate immune cells are designed to defend the host organism against 
pathogens by detecting pathogen-associated molecular patterns (PAMPs), such as 
lipopolysaccharide (LPS), through pattern recognition receptors (PRRs) and 
eliminate the observed pathogens while maintaining self-tolerance  [3, 5, 6]. PAMPs 
e.g. LPS, originate from gram-negative bacteria and activate immune cells [7]. Once 
the innate immune cells are activated, they clear pathogens from the organism by 
phagocytosis, or they lyse microbes through released antimicrobial peptides [8].  
 
Further, activated innate immune cells secrete several types of molecules to 
the environment, such as cytokines. Cytokines are divided into pro- and anti-
inflammatory cytokines [9]. Pro-inflammatory cytokines are able to recruit cells to 
the sites of infection via their chemotactic activity and activate endothelial cells to 
upregulate the adhesion molecules expression on their surface [10, 11]. The 
cytokine family includes chemokines, interleukins (IL) and tumor necrosis factor 
(TNF). 
 
However, circulating immune cells adhere to the activated endothelium via 
the endothelial cell-expressed adhesion molecules and selectins and its leukocyte 
expressed respective ligands. The recruitment cascade of leukocytes includes cell 
rolling on the endothelium, cell adhesion, and transmigration into the inflamed tissue 
[11].  
 
 The first line of defense is built by the most abundant circulating leukocyte 
in human organism, the neutrophils. They account for 50-70% of the circulating 
leukocytes. Neutrophils are scavenging phagocytes that clear pathogens from the 
environment [12]. They are recruited to the site of infection or injury to trigger the 
inflammatory response [13]. In sterile inflammation, where no bacterial particles are 
present, the recruitment of neutrophils is mediated by e.g. danger-associated 
pattern molecules (DAMPs) released from damaged tissue or cells [14]. Neutrophils 
migrate to the site of inflammation to neutralize the pro-inflammatory particles and 
promote the recruitment of monocytes, which potentiate the pro-inflammatory 
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environment [15, 16]. When particles as DAMPs are cleared, neutrophils undergo 
apoptosis and are ingested by macrophages. The clearance of apoptotic cells 
promotes resolution of inflammation [17]. If this mechanism is imbalanced, chronic 
inflammation can occur and cause different types of diseases such as 
atherosclerosis [18]. 
 
1.2.  Neutrophils    
 
Neutrophils belong to the innate immune system, constitute the first line of defense, 
and account for up to 70% of the human circulating leukocytes under steady-state 
conditions. During hematemesis up to 2 x1011 neutrophils are produced daily, 
originating from hematopoietic stem cells [19]. They are characterized by a 
multilobulated nucleus and equipped with a variety of cytoplasmic granules, which 
are formed during neutrophil maturation in the bone marrow, a process called 
granulopoiesis [13, 20].  Recent studies have shown that circulating neutrophil 
numbers are fluctuating under steady-state conditions, following circadian 
rhythmicity [21-23].  
 
Neutrophils play an essential role during infection and injury. To control 
infections, neutrophils can eliminate pathogens in multiple ways either intracellular 
or extracellular. They engulf pathogens by phagocytosis into phagosomes and 
eliminate them by nicotinamide adenine dinucleotide phosphate (NADPH) 
oxygenase produced reactive oxygen species (ROS) and antimicrobial granules 
proteins which are translocated into the lysosome [24-27]. The granules, which store 
the granule proteins, are formed during different stages of maturation with varying 
produced proteins and are composed of diverse proteins [28]. In mature neutrophils 
are three different kinds of granules incorporated: the azurophilic granules (primary), 
specific (secondary) granules, and gelatinase (tertiary) granules. Additionally, 
secretory vesicles can be found in mature neutrophils (Figure 3). These granules 
store antimicrobial proteins which are important for pathogen clearance. The 
azurophilic granules contain myeloperoxidase and antimicrobial proteins, such as 
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cathepsin G. The later formed granules can be divided into specific (secondary) and 
gelatinase (tertiary) granules. Specific granules are filled with cytotoxic proteins as 
cathelicidin LL-37. Whereas, gelatinase granules are packed with matrix 
degradation enzymes gelatinase and lysozyme, which are important during 
neutrophil extravasation and diapedesis to reach the site of inflammation. 
Additionally, mature neutrophils show ficolin-1 granules and secretory vesicles that 
are rich in CD11b/CD18 promoting firm adhesion and endothelial transmigration. 
The granular proteins are released from activated neutrophils during a process 
called degranulation [28-30] 
 
Figure 3:  Neutrophil granules proteins. 
Neutrophils bear characteristic granules with related proteins. The azurophilic granules (primary, 
green) contains myeloperoxidase, proteinase 3, and cathepsin G. Specific granules (secondary, 
yellow) are filled with lactoferrin, laminin, fibronectin, and NADPH-oxidase. Whereas, gelatinase 
granules (tertiary, brown) are packed with matrix degradation enzymes gelatinase and lysozyme, 
which are important during neutrophil extravasation and diapedesis. Additionally, mature neutrophils 
show secretory vesicle (purple) which are rich in CD11b/CD18 promoting firm adhesion and 
endothelial transmigration. Main figure components from https://smart.servier.com/. 
 
As mentioned before, neutrophils are phagocytes and can efficiently kill 
pathogens in the phagosomes, where the antimicrobial granule proteins and ROS 
orchestrate an antimicrobial environment. Furthermore, neutrophils can also 
degranulate their granules proteins into the environment. Antimicrobial proteins like 
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LL-37 bind pathogen surface and are able to lyse bacteria [31]. Alternatively, 
neutrophils can eliminate or entrap microorganisms extracellular by releasing 
neutrophil extracellular traps (NETs) (Figure 4) [32, 33].  
 
 
Figure 4: Neutrophil defense mechanisms. 
Neutrophils exhibit different defense mechanisms. To protect the host neutrophils can release 
preformed granule proteins during degranulation or phagocyte invaders. Additionally, neutrophils are 
able to release extracellular traps to prevent pathogens from spreading. These NETs are decorated 
with granule proteins which have a microbicidal effect. Figure adapted from Kolaczkowska, E. 2013 
[13]. Main figure components from https://smart.servier.com/.  
 
However, released neutrophil-derived granule proteins can also attract 
monocyte to the sites of infection or injury. LL-37 and cathepsin G, for instance, are 
chemotactic for monocytes and α defensin in complex with chemokines has been 
shown to support monocyte adhesion [16, 34-36]. 
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1.3. NETs 
 
Neutrophils, as an essential part of the innate immune response, show phagocytic 
and antimicrobial activity upon infection to protect the host from damage and to 
ensure host survival [12]. In order to eliminate pathogens, neutrophils release 
preformed granule proteins to the environment, a process called degranulation, or 
phagocyte pathogens [27]. In 2004, Brinkmann et al. postulated a new defense 
strategy [32]. They observed the release of neutrophil chromatin to the environment 
upon neutrophil activation by microbes [37]. These chromatin structures are called 
neutrophil extracellular traps (NETs). They are released to limited pathogen 
spreading [33, 38]. NETs are decorated with granule proteins [39]. The granule 
proteins have a microbicidal activity to limit pathogen spreading [30] (Table 1). 
 
Table 1: neutrophil extracellular trap associated proteins. 
Summary of the main neutrophils-derived proteins, which decorate expelled neutrophil extracellular 
traps. Besides antimicrobial peptides or enzymes, also cell membrane-fragments from neutrophil 
membrane break up can be detected in NETs. Table adapted to Urban, C. 2009 [39]. 
compartment protein 
histones H1, H2A, H2B, H3, H4 
primary granules Neutrophil elastase, cathepsin G, 
myeloperoxidase, defensins, cationic antimicrobial 
protein CAP37 
secondary granules lactoferrin, lysozyme, NADPH oxidase, 
cathelicidins 
tertiary granules cathepsin, metalloprotease, gelatinase 
cytosol proteinase 3, LL-37, S100 calcium-binding protein 
A8, -A9, -A12 
cytoskeleton actin, myosin-9 
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Neutrophils form NETs upon activation by pathogens like viruses, fungi, 
bacteria, and its products LPS and fMLP. Besides pathogens also host-derived 
autoantibodies, platelets, and cholesterol crystals have been shown to cause NET-
formation (Figure 5) [32, 37, 40-45]. NETosis is regulated by the microbes’ size [37]. 
Large microbes cause NETosis more likely than small pathogens, which can easily 
phagocyte into phagosomes [46]. Extracellular trap formation is also not restricted 
to neutrophils, mast cells and eosinophils have been described to form extracellular 
traps as well [47-49]. 
 
Figure 5: Trigger to release neutrophil extracellular traps. 
Recently different NET-inducers have been described as visualized in the scheme. Apart from 
pathogens as viruses, fungi, or bacteria an also parts of pathogens can induce NET-formation. 
Besides pathogens, also host-derived components are sufficient NET-inducer like platelets or formed 
autoantibodies. Main figure components from https://smart.servier.com/. 
 
Recent work has shown, that the neutrophil extracellular trap formation 
pathway is dependent on its stimulus [50]. The first investigations, focusing on 
NETs, stimulated neutrophils with phorbol myristate acetate (PMA) [32]. This NET-
formation was later called NETosis due to cell death after NET-release [32, 33, 51]. 
However, this NET-formation mechanism was challenged by observations showing 
extracellular traps originating rather from mitochondrial deoxyribonucleic acid (DNA) 
than from genomic DNA, which was defined as vital NET-formation [52]. During vital 
NET-formation mitochondria are lysed to release the mitochondrial DNA. NETs 
formed from mitochondrial DNA are supposed to be vital since the neutrophils cell 
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membrane is not lysed and it has been observed that neutrophils are still able to 
phagocyte after they performed NET-release [53].  
 
Besides differences in vital or suicidal NET-formation, also different NET-
formation cascades have been described: the NADPH oxidase-dependent and 
NADPH oxidase-independent pathway. Antibodies, pathogens, and its products 
released from e.g. Escherichia coli or PMA induce the NADPH oxidase-dependent 
NET-formation [54, 55]. Upon stimulation, the cell cycle proteins cyclin-dependent 
kinase 4 and 6 are activated and NADPH oxidase forms reactive oxygen species 
(ROS), which in turn causes the degranulation of azurophilic granules into the 
cytoplasm, thereby leading to neutrophil elastase (NE) translocation into the nucleus 
[56, 57]. This protease degrades linker histones H1, causing chromatin relaxation. 
Due to DNA decondensation and nucleus swelling, the nuclei membrane disrupts, 
and chromatin is mixed with cytoplasm associated proteins [58]. In addition, NE also 
cleaves gasdermin D into its active form, leading to pore formation into granule 
membrane and cell membrane [59, 60].  Finally, the cell membrane breaks down 
and the chromatin-protein mixture is released into the environment as neutrophil 
extracellular traps (Figure 6). Released NETs are web-like DNA fibers composed of 
genomic DNA and are associated with 24 proteins: 11 cytoplasmatic proteins, 2 
glycolytic enzymes, 5 cytoskeletal proteins, 3 S100 proteins, and the histones H2A, 
H3, and H4, which are the most abundant proteins in NETs [39].  
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Figure 6: NADPH oxidase-dependent Neutrophil extracellular trap release. 
One well-described pathway of NET-formation is illustrated, but the detailed cascade is still under 
discussion. Nevertheless, DAMPs or PAMPs activated neutrophils leading to granules protein 
release into the cytoplasm. One of the released proteins is myeloperoxidase, which catalyzes the 
reactive oxygen species (ROS) production causing oxidative stress. Further, NE originating from 
neutrophil granule is translocated into the nucleus. NE cleaves the histone. This process leads to a 
nucleus swelling, the breaks of the nuclei membrane lead to chromatin mixing with the cytoplasm. 
Finally, the cell membrane breaks down resulting in chromatin granule protein mixture exposure to 
the environment, recognized as neutrophil extracellular traps. Main figure components from 
https://smart.servier.com/. 
 
NADPH oxidase-independent NET-formation can be caused by 
Streptomyocin-derived calcium ionophore A23187 [61]. This pathway is 
independent of ROS and neutrophil elastase. However, the histone H3 citrullination 
through peptidylarginine deiminase 4 (PAD4) is characteristic of the NADPH 
oxidase-independent pathway [62, 63]. PAD4 converts histone arginine to citrulline, 
resulting in a loss of positive charge on arginine residues and leading to chromatin 
decondensation [62]. Nevertheless, the complete mechanism of the NADPH 
oxidase independent pathway is not fully understood. 
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Neutrophil extracellular traps are formed upon infections to entrap bacteria 
[32]. Recent studies have shown that many pathogens evolved different strategies 
to escape NETs. Streptococcus pyogenes and Streptococcus pneumoniae 
synthesize DNase and digest NET-backbone structure DNA to escape NETs [64]. 
Others neutralize the pore-forming effect of LL-37 by protein M1 [65]. Furthermore, 
the defined surface charge, with varying d-alanyl residues expression of pathogens 
surface can prevent NET-entrapment. Pathogens lacking d-alanyl are entrapped 
due to charge interaction and can be killed by NETs [66]. Besides pathogens, also 
cholesterol crystals and autoantibodies were described to cause NET-formation and 
play a critical role in autoimmunity and chronic inflammation [43, 67-69].  
 
Since extracellular DNA and the reactive granule proteins can cause 
inflammation, a well-balanced process between NET-release and clearance is vital. 
In order to regulate this process, NETs are cleared by DNAse I and DNAse I L3 in 
mice. Therefore the absence of these enzymes can lead to lethal NET-caused 
thrombosis [69, 70].  
 
1.4. Monocytes 
 
Monocytes belong to the innate immune system and are of myeloid origin. They 
develop in the bone marrow from the common myeloid progenitor, where also 
neutrophils originate from [25, 71]. Mature monocytes are released from the bone 
marrow to the circulation. The spleen is apart from lung and skin a peripheral 
extramedullary reservoir for monocytes [72, 73]. Monocytes account for 10 % of 
human circulating leukocytes [74]. They are phagocytic cells and play a critical role 
in infection and homeostasis. The monocyte subset in mice can be divided into 
inflammatory and anti-inflammatory monocytes, whereas in humans patrolling 
monocytes were discovered additionally [75-77]. Patrolling monocytes scan the 
vasculature and support the resolution of inflammation. In contrast, inflammatory 
monocytes express high levels of cytokines, e.g. tumor necrosis factor α and 
interleukin -1 (IL-1) to fuel inflammation and can differentiate into dendritic cells or 
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macrophages at the sites of infection, clearing pathogens from the organism [75]. 
Nevertheless, excessive monocyte activation causes tissue damage and trigger 
chronic inflammation [78-80].  
 
1.5. Leukocyte recruitment 
 
Leukocyte recruitment from bone marrow or spleen during infection or sterile 
inflammation requires the ability to sense signals, adhere, and finally transmigrate 
into the tissue. Tissue-resident cells, such as macrophages and dendritic cells, 
detect PAMPs from pathogens or DAMPs released from damaged cells and secrete 
in turn pro-inflammatory stimuli such as cytokines that activate endothelial cells to 
upregulate adhesion molecule expression and initiate leukocyte adhesion. The 
leukocyte adhesion on endothelial cells processes in a cascade-like manner [81].  
 
First of all, leukocytes are captured from circulation on the endothelium. The 
cells slow down and finally arrest. Following leukocyte arrest on the endothelium, 
the cell adhesion is strengthened, and adherent leukocytes can transmigrate 
through the endothelium to reach the sites of inflammation. During every step of 
leukocyte recruitment, specific molecules play a critical role [11]. Capturing 
leukocytes on endothelial cells is dependent on P-selectin glycoprotein ligand 1 
(PSGL1) and very late antigen 4 (VLA4), which are also involved in rolling and the 
interaction of the cell adhesion molecules intercellular adhesion molecule 1 (ICAM1) 
and vascular cell-adhesion molecule 1 (VCAM1) [82, 83]. Furthermore, inflamed 
endothelial cells express E- and P-selectin, which interact with leukocyte expressed 
PSGL1 [84]. The interaction of selectins with their ligands enables them to adhere 
to endothelial cells. Additionally, integrins such as VLA4 and lymphocyte function-
associated antigen 1 (LFA1) or macrophage antigen 1 (MAC1) mediates leukocyte 
rolling through their adhesion molecule VCAM1 or ICAM1 [85]. During inflammation, 
endothelial cells are activated in order to upregulate adhesion molecule expression 
and release chemokines [86]. Chemokines are chemoattractants triggering the 
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arrest of rolling leukocytes through g- protein coupled receptor interaction.  Adherent 
leukocyte crawl on the endothelium to find a site to transmigrate into the tissue either 
transcellular or paracellular (Figure 7) [11]. 
 
 
Figure 7: Leukocyte recruitment 
Leukocyte recruitment cascade includes capturing of circulating cells, cell rolling on endothelium, 
leukocyte arrest and adhesion strengthening followed by crawling and finally transmigration. Figure 
adapted from Ley, K. 2007 [11]. Main figure components from https://smart.servier.com/. 
 
1.6. Neutrophil pioneer monocytes to inflammatory 
sides 
 
Neutrophils as the most abundant leukocytes in human peripheral blood are the first 
cells recruited to the site of infection and inflammation [12]. The first wave of 
polymorphonuclear leukocytes is followed by a second wave of monocytes 
recruitment by released soluble factors with attracting properties (Figure 8) [87]. This 
phenomenon can be explained by different kinds of adhesion molecules that 
facilitate leukocyte adhesion. Adhesion of neutrophils is most likely dependent on 
preformed or rapidly enzymatic cleaved molecules, which are easily externalized by 
neutrophils [35]. However, the classical adhesion pathway of monocytes requires a 
sequence of molecular interactions between monocytes and the endothelium. 
Selectins expressed on activated endothelium enables monocytes to roll on 
- 14 - 
 
endothelial cells and slow down [11]. Next, monocytes are exposed to chemokines 
presented on the endothelial surface, activating monocytes to firmly adhere. Finally, 
monocytes are activated for transendothelial migration and extravasation.  
 
In addition to the classical adhesion pathway of monocytes,  activated 
neutrophils can release preformed granule proteins on the endothelium to launch 
monocyte recruitment [16, 28, 29, 88, 89]. In line with this, it was shown that the 
lysate of neutrophils can cause monocyte chemotaxis [90]. In contrast, neutrophils 
from patients deficient in granule proteins did not cause monocyte chemotaxis. 
These findings indicate that granule proteins are crucial in monocyte recruitment, 
providing a second reason for monocytes being the second wave of recruited 
leukocytes to the site of injury or inflammation upon neutrophil recruitment [88].  
 
 
Figure 8: Leukocyte recruitment wave. 
This graphical scheme shows the neutrophil and monocyte recruitment timing after injury. Classically, 
neutrophils are viewed as the first line of defense and are the first cells recruited to the site of 
inflammation or injury within minutes. This first wave is followed by a second wave of recruited 
monocytes. Main figure components from https://smart.servier.com/. 
 
Neutrophils have various mechanisms for inducing monocyte recruitment. 
Upon binding to adhesion molecules expressed on endothelial cells, neutrophils 
release the content of secretory vesicles, which contain besides membrane 
receptors, proteinase-3, and the cationic antimicrobial protein of 37 kilo Dalton (kD) 
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(CAP37), among others [16]. These two proteins are able to activate endothelial 
cells to increase VCAM1 and ICAM1 expression on their surface, leading to 
enhanced monocyte and neutrophil adhesion. Additionally, integrins expressed on 
monocytes facilitate monocyte binding to both, proteinase-3 and CAP37. In this 
respect, it was also shown that neutrophil released LL-37, cathepsin G as well as 
the chemokine CCL2 can cause monocyte recruitment [16, 34, 91]. Interestingly, 
neutrophils can establish a partnership with other cells to induce monocyte 
recruitment. Thus, neutrophil released α defensins (HNP 1) form heterodimers with 
platelet-secreted CCL5 to promote monocyte adhesion [92]. In addition, 
myeloperoxidase released from primary granules causes monocyte adherence to 
endothelial cells as well. The granule proteins are highly cationic proteins, which 
bind to the anionic charge endothelial cell membrane [93]. The charge of the cell 
membrane is determined by glycoproteins and glycolipids expressed on the cell 
surface, called glycocalyx [94]. Noteworthy, leukocytes also show negatively 
charged surface glycocalyx, which causes adhesion to cationic granule protein MPO 
via charge interaction, a mechanism independent on adhesion molecules [93]. 
 
 
1.7. Neutrophils and monocytes in disease 
 
Neutrophils and monocyte's interaction during innate immune response enables the 
host to efficiently defend against pathogens. Both cell types arise from the same 
precursor cells, therefore, it has been assumed that they potentially show common 
features [25, 71]. In fact, neutrophils and monocytes are both phagocytes, that can 
release effector molecules, such as cytokines, upon activation. Traditionally, 
neutrophils are described to be the first recruited cells to sites of infection, followed 
by a second wave of monocytes [87]. Neutrophils and monocytes together 
orchestrate an enhanced immune response. They regulate other immune cells and 
each other by releasing determined cytokines. Neutrophil clearance from the site of 
infection induces an important signal to resolve inflammation and limit leukocyte 
recruitment [95]. However, if this efficient pathogen elimination mechanism is not 
well balanced, the neutrophil-monocyte interplay can lead to tissue damage leading 
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to chronic inflammation. Chronic inflammation occurs if the immune system clears 
insufficient the initiating immune response signals, as PAMPs and DAMPs, or if the 
resolution of inflammatory response malfunctions [96]. 
 
 One prominent chronic inflammatory disease is atherosclerosis. 
Atherosclerosis is characterized by the chronic inflammation of large and medium-
sized arteries leading to peripheral vasculature disease [97]. Elevated low-density 
lipoprotein levels and hypercholesterolemia are one of the major risk factors for 
atherosclerosis. It has been shown that hypercholesterolemia increases neutrophil 
levels in circulation, which is known as neutrophilia. In fact, neutrophilia is a potent 
initiator of plaque development. If the amount of circulating neutrophils is decreased, 
reduced numbers of monocyte can be detected within the lesion, leading to 
moderated plaque development [98, 99]. 
 
1.8. Atherosclerosis  
 
Atherosclerosis, a complex and progressive lipid-driven disorder of the arterial 
vessel wall, is known as a chronic inflammation, where disease progression is a 
consequence of the failed resolution of inflammation. It is the primary 
pathophysiology of cardiovascular disease (CAD) whose clinical outcome has life-
threatening consequences. The most common risk factors for atherosclerosis are 
hyperlipidemia, hypertension, or smoking. Even though the treatment of well-
established risk factors, CADs are still the leading cause of mortality [100].  
   
Usually, the arterial vessel wall is composed of the intima, the media, and the 
outer layer called the adventitia. The intima, the inner layer closest to the 
bloodstream, is formed by a single endothelial cell layer as well as connective tissue 
consisting of collagen, elastin, and proteoglycans. As mentioned before (1.5), in 
steady-state, the endothelial cells are not capable to bind leukocytes. Upon 
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activation, caused by infection or injury, the expression of the adhesion molecules 
E-selectin, P-selectin, or ICAM-1 and VACAM-1 is upregulated and enables 
leukocyte adhesion [101]. Further, activated endothelial cells secrete chemokines 
to recruit leukocytes. The shift of physiologic endothelium function to a pro-
inflammatory state is characteristic of endothelial dysfunction. Endothelial 
dysfunction, including the permeability of the endothelium for plasma components, 
such as low-density lipoprotein (LDL), is a response to risk factors causing 
atherosclerosis [102]. Atherosclerotic lesion formation occurs in the intima, where 
translocated modified LDL is engulfed by macrophages causing foam cell formation 
and results in an initial step for fatty streak formation.  Over time, fatty streaks 
develop into advanced atherosclerotic lesions. Inflammatory cells accumulate in the 
lesion, thereby promoting inflammation. The growing lipid core is covered by fibrous 
connective tissue forming the fibrous cap of the atherosclerotic lesion [103]. 
However, the pro-inflammatory environment leads to increased cell death within the 
lesion, resulting in necrotic core formation and fibrous cap thinning (Figure 9). If the 
plaque ruptures, the highly pro-thrombotic and pro-coagulant atherosclerotic lesion 
content is exposed to the bloodstream leading to thrombus formation and vessel 
occlusion. Dependent on the site, this event can lead to myocardial infarction or 
stroke [104]. 
 
Figure 9: Atherosclerosis development: different stages.  
The different stages of atherosclerosis development from normal healthy vessels to advanced plaque 
are shown. Atherosclerosis develops over decades where an initial fatty streak grows into a fibrous 
plaque up to vulnerable plaque. Main figure components from https://smart.servier.com/. 
 
Atherosclerotic lesion formation occurs on large and medium-size arterial 
vessels at branch points, bifurcation, or curvature where the laminar flow is 
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disrupted. Endothelial cells at branch or curvature site show, in comparison to 
tubular regions, a polygonal shape. These areas, such as common carotid and left 
coronary arteries, have flow alterations and are typically sensitive to 
macromolecules deposition such as LDL [105].  Circulating LDL is transported by 
apolipoprotein B100 (ApoB100) and can accumulate within the intima by binding to 
proteoglycans of endothelial cells [106]. Finally, diffused LDL is oxidatively modified 
(oxLDL) by reactive oxygen species or enzymes originating from neutrophils or 
macrophages and is, therefore, a potent trigger of inflammation [107]. Additionally, 
oxLDL-causes endothelial cells activation resulting in a release of chemokines and 
cytokines. This causes leukocytes recruitment and the upregulation of adhesion 
molecules expression on the endothelium thereby facilitating leukocyte adhesion 
and transmigration into the intima [108, 109]. Transmigrated monocytes differentiate 
into macrophages which phagocytose oxLDL. At first glance, macrophages 
phagocyting oxLDL might clear the environment from pro-inflammatory agents, 
thereby limiting the inflammatory stimulus. However, lipid-laden macrophages 
become foam cells that secret pro-inflammatory factors and promote cell recruitment 
[110]. This early stadium of fatty streak development is reversible. Progressive 
atherosclerosis is later characterized by intimal thickening with typical extracellular 
lipid accumulation. Plaque progression is triggered by foam cell necrosis forming 
early fibro atheroma. The lipid-rich necrotic core is enclosed by smooth muscle cells 
forming the fibrous cap, which stabilize the lesion by secreting elastin and collagen 
[104]. Lesional macrophages secrete chemokines, including CCL2, to increase 
leukocyte recruitment into the plaque [98, 111]. Furthermore, the release of pro-
inflammatory factors, such as interferon- γ and tumor-necrosis factor leads to a 
complex atherosclerotic lesion, where smooth muscle cell migration and 
proliferation contributes to stable lesion formation [112, 113]. However, 
macrophages promote plaque destabilization by releasing metalloproteinases 
(MMP), that in turn digest extracellular matrix proteins. This process leads to 
thinning of the fibrous cap resulting in plaque rapture (Figure 10) [114, 115].   
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Figure 10: Development of atherosclerosis. 
The physiological artery consists of three layers including intima, media, and adventitia (a). 
Atherosclerotic lesion development is initialized by activated endothelium expressing adhesion 
molecules which leads to enhanced leukocyte adhesion and migration. Monocyte-derived 
macrophages become foam cells upon oxidized lipid uptake (b). Atheroprogression is characterized 
by smooth muscle cell (SMC) migration from the media as well as SMC proliferation (c). In advanced 
atherosclerotic lesion, cell death of foam cells or SMC leads to necrotic or lipid core formation due to 
lipid release from dying cells (d). Figure from Libby, P. 2011 [103]. 
 
In addition to monocytes and monocytes-derived macrophages, neutrophils 
are supposed to play a critical role in atherosclerosis as well [95]. Peripheral 
neutrophil numbers increase under hypercholesterolemia conditions and are 
associated with an increased lesion size [98]. Neutrophil homeostasis is well 
regulated by the chemokine receptors CXCR2 and CXCR4 and their agonists 
CXCL1 and CXCL12 [116]. During hypercholesterolemia conditions neutrophil 
mobilizing chemokines, CXCL1, and CXCL8 are highly secreted by activated 
endothelial cells, causing an increased amount of circulating neutrophils [117, 118]. 
ICAM-1 upregulation on endothelial cells causes neutrophil adhesion, resulting in 
neutrophil-derived proteinase-3 and azurocidin release, which in turn triggers 
increased leukocyte adhesion, eventually leading to intima thickening [118, 119]. As 
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mentioned before, during neutrophil extravasation, neutrophils release granular 
proteins, which promote monocyte recruitment [120]. Additionally, neutrophil 
derived MPO modifies LDL oxidatively within the lesion, leading to increased lipid 
accumulation within the intima and foam cell formation. Therefore, neutrophils play 
a pivotal role during atheroprogression and plaque vulnerability. Neutrophils tend to 
accumulate close to the fibrous cap where released MMPs digest extracellular 
matrix [121-123]. Furthermore, activated neutrophils are able to release neutrophil 
extracellular traps, presenting certain granule proteins as well as NET-associated 
histones [39]. The presence of histones in atherosclerotic lesion has recently been 
shown to increase overall lesion vulnerability, characterized by lesion size and 
necrotic core area, while its neutralization improved lesion stability [124].  
 
1.9. NETs in disease 
 
Neutrophils as the first line of defense are able to form extracellular traps to bind 
pathogens by electrostatic forces, preventing their spread. However, an unbalanced 
NET production and clearance can be deleterious [125, 126]. During infections, 
these expelled traps persist for serval days [37]. Mechanisms to clear NETs are less 
well studied yet. It has been described that plasma DNAse degrades NETs and also 
macrophages can clear NETs from the environment [69, 127, 128]. Therefore, an 
equilibrium between NET production and clearance is essential, and any unbalance 
can cause diseases [54, 129]. Erythrocytes and platelets are easily trapped in NETs 
and initiated coagulation, leading to deep vein thrombosis [130]. Similarly, 
inappropriate cleared NETs can cause tissue damage according to their highly toxic 
components [131, 132]. As an example histones are the most abundant proteins 
associated with NETs and are highly toxic to endothelial cells  [39, 133].  Further, it 
was shown that neutrophil extracellular traps can cause hepatic tissue damage 
during sepsis due to histone exposure to the environment. This effect was prevented 
in neutrophil elastase or PAD4-deficient mice which showed limited NET-formation 
[131].  
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Moreover, persistent neutrophil extracellular traps are potential causes of 
chronic inflammation, such as cystic fibrosis or atherosclerosis, or autoimmune 
diseases like arthritis or systemic lupus erythematosus (SLE) [43, 67, 132, 134, 
135]. Chronic inflammation results from failed pro-inflammatory stimulus clearance 
as well as the initiation of the pro-resolving phase followed by tissue repair [136]. As 
mentioned, NETs contribute to chronic inflammation by stimulating other immune 
cells for cytokine release, which is a potent trigger of inflammation. In patients with 
cystic fibrosis, macrophages fail to clear NETs leading to massive inflammation 
[137]. Interestingly, patients who inhaled DNAse to degrade NETs had decreased 
NET-levels in the mucus and even an increased lung function was shown in mice 
[134].  
 
Besides inappropriate NET-clearance, also uncontrolled NET-formation can 
cause diseases. So-called low-density neutrophils, found in an autoimmune disease 
like SLE are likely to form NETs spontaneously [138, 139]. SLE patients show 
autoantibodies against extracellular DNA, histones, and neutrophil antigens, which 
are all detectable in NETs. Autoantibodies have been reported to induce NET-
formation leading to a vicious cycle of disease. SLE patients also show a decrease 
in DNAse I activity, which is produced and secreted by the pancreas, leading to a 
lack of NET-clearance [69].  Interestingly, NET-associated proteins can persist on 
the endothelium after DNA digestion. The von Willebrand factor (VWF) has been 
suggested to be a potent NET-protein binder by blocking VWF, which limited tissue 
damage [131]. The cytotoxic effect of NET-associated proteins has also been 
described in atherosclerosis, where endothelial dysfunction and smooth muscle cell 
lysis by NET-associated proteins resulted in vulnerable plaques [67, 124]. 
Consequently, genetic depletion of PAD4 in mice leads to reduced atherosclerotic 
lesion size or even reduces plaque vulnerability [124, 140]. Studies focusing on 
atherosclerosis, diabetes, or cancer highlight the impact of NETs in disease 
progression. Taken together,  these studies show that not only the unbalanced NET-
formation or -clearance fosters chronic inflammation, but also constant sterile 
inflammatory trigger, such as recurrent cigarette smoke inhalation, high fat and high 
cholesterol diet promotes chronic inflammation and thus pose a challenge [55, 141-
143]. 
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1.10. Endotoxemia 
 
Endotoxins are small bacteria-derived molecules known as 
lipopolysaccharides (LPS) which are present in the outer membrane of gram-
negative bacteria or cyanobacteria. They belong to the pyrogens, inducing 
inflammation. Bacteria extrude large amounts of LPS upon cell death, growth, and 
cell division. Approximately two million LPS molecules can be found in a single 
Escherichia coli cell membrane [144, 145]. LPS is a complex molecule consisting of 
a core polysaccharide chain, a hydrophilic O-specific polysaccharide chain, and the 
toxic lipophilic lipid component (lipid A) which can bind to the macrophage 
scavenger receptor or CD11b/CD18 [146]. Additionally, circulating LPS binds to the 
LPS binding protein (LBP). The 60 kDa LBP is a soluble acute-phase protein that 
interacts with monocytes and macrophages associated glycoprotein CD14 signaling 
through the TLR-4 MD-2 complex (Figure 11). This in turn activates pro-
inflammatory cytokines production triggering inflammation [147]. Epidemiological 
studies show that circulating LPS (endotoxemia), can occur in apparently healthy 
subjects as well [148]. Circulating endotoxins might originate from gut microbiota, 
smoking, chronic infections, or recurrent infections. The link of circulating infectious 
agents to early atherosclerosis was already drawn in the late 1970s [149-151]. 
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Figure 11: LPS interacting receptors.    
Lipopolysaccharide binds LPS binding protein (LBP). This complex can interact with CD14 causing 
a signaling pathway through Toll-like receptor 4. Alternatively, macrophage scavenger receptor 
(MSR) or CD11b/CD18 expressed on the cell membrane sense LPS. Adapted from Cohen, J. 2002 
[152]. 
 
1.11. Endotoxemia accelerates atherosclerosis 
 
A growing body of evidence indicates infections as an additional potent risk factor 
causing atherosclerosis. This link has been drawn according to the seasonal 
incidences to suffer from myocardial infarction, which is higher during cold seasons 
when infections more frequently occur [153]. Retrospective studies analyze primary 
care data-settings revealing an increased risk to suffer from cardiovascular disease 
within the first days following an acute respiratory infection [154, 155]. Pathogens 
infecting the non-vasculature site can release pathogen-associated particles in the 
circulation, like PAMPs such as LPS, causing a systemic inflammatory response. 
Studies focusing on lung infection with gram-negative bacteria Chlamydia 
pneumoniae showed an increased atherosclerotic lesion size up to 70% compared 
to non-infected mice [156-159]. LPS causes pro-inflammatory response as 
upregulation of adhesion molecules on endothelial cells and increased cytokine 
production also by lesion associated macrophages, increasing leukocyte 
- 24 - 
 
recruitment [160, 161].  Further, it has been shown that polarized monocytes cause 
a dramatic increase in atheroprogression during endotoxemia [162]. Besides 
leukocytes and endothelial cells also platelets are activated by LPS which can lead 
to platelet-neutrophil crosstalk by forming CCL5 and HNP-1 heterodimers, which 
foster monocyte adhesion. Moreover, CCL5 can potentially cause neutrophil 
extracellular trap formation and fuel inflammation [92, 163]. In addition to CCL5, also 
activated platelets have been shown to induce NET-formation under endotoxemia 
conditions [164]. Neutrophil extracellular traps are able to cause endothelial 
dysfunction, which enhances leukocyte adhesion and accelerates atherosclerosis. 
This effect can be limited by pharmacological blocking of PAD4 with Cl-amidine 
which inhibits NET-formation [135]. Furthermore, if NETs are released within the 
atherosclerotic lesion, the NET-associated proteinases and histones affect plaque 
stability [67, 124, 141, 165]. 
 
1.12. Therapeutical approaches  
 
Atherosclerosis develops over decades and starts with fatty streak development 
when LDL enters the arterial intima and accumulates over time [166]. The first 
changes occur at branch points and lead to increased endothelial cell adhesion 
molecules expression initiating leukocyte adhesion, fuel inflammation. Chronic 
inflammation is a key characteristic of atherosclerosis and its limitation seems to be 
a promising therapeutical strategy. Hypercholesterolemia has been described to 
cause neutrophilia to accelerate early atherosclerosis [98]. Treatment of 
hypercholesterolemia including statin therapy as shown in the JUPITER study has 
shown that the lowering of LDL levels leads to reduced risk to suffer from CVD [167, 
168]. Nevertheless, recent studies suggest that lipid-lowering therapy can promote 
diabetes mellitus incidence [169, 170].  
 
High lipid levels are associated with increased circulating neutrophils, which 
is strongly associated with accelerated atherosclerosis. Therefore, inhibition of 
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leukocyte adhesion is a potent strategy to limit inflammation and atheroprogression 
[98, 171, 172]. However, leukocyte adhesion at the site of infection is a crucial step 
to reach pathogens and eliminate them. Inhibition of leukocyte adhesion could lead 
to insufficient immune response during infection [173]. Interestingly, acute 
respiratory infections were shown to increases the risk to suffer from CVD [154, 
155]. During infection, neutrophils are able to form neutrophil extracellular traps, 
which in turn cause endothelial dysfunction leading to atherosclerotic lesion growth 
[32, 135]. Additionally, NET-formation within the lesion has been shown to cause 
plaque vulnerability [124]. However, antibiotic treatment during infection seems not 
to prevent cardiovascular events but vaccination is shown to potentially lower the 
risk [174, 175]. Interestingly, mice studies genetically blocking NET-formation result 
in smaller lesion size [135]. These studies point to the important role of NETs during 
atherosclerosis and stress out the importance to understand the underlying 
mechanism to develop specific treatment strategies. 
 
1.13.  Research Rational 
 
Atherosclerosis is a chronic inflammatory disease. Over the decades, 
atherosclerotic lesion develops in the large arteries and is composed of 
accumulated leukocytes and lipids. The literature ascribes macrophages as a major 
part of lesion development. However, there is a growing body of evidence pointing 
on neutrophils to play an important role during atherosclerosis development. 
Neutrophils generate reactive oxygen species, release granules proteins, cytokines, 
and neutrophil extracellular traps (NETs) and therefore fuel inflammation. NETs are 
complex DNA-structure composed of antimicrobial peptides, which are released 
upon infection or host-derived stimuli. NETs are described to entrap bacteria, 
preventing their spread in the host organism. Noteworthy, previous in vivo studies 
show reduced lesion formation if NET-release is blocked. NETs are able to cause 
endothelial dysfunction and therefore may trigger monocyte attraction. They are 
formed during infection to entrap bacteria and there is evidence that infection 
increases the risk to suffer from myocardial infarction. However, these studies lack 
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to show the relation of NETs and accelerated atherosclerosis during infection. 
Therefore, the present study aims to understand the pathophysiological mechanism 
of NETs in atheroprogression in the context of endotoxemia. The result of this study 
will contribute to a better understanding of NET-mediated atherosclerosis 
development and may serve to elucidate a therapeutic strategy to limit 
atherosclerosis.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
- 27 - 
 
 
2. Methodology 
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2.1. Methodology 
 
To run the different in vitro and in vivo assays the following buffers and solutions 
were used unless otherwise stated in the text. 
 
Table 2: Buffer and solutions 
Buffers and solutions which were used in experiment settings unless otherwise stated differently. 
Solutions were prepared as described in the recipe. 
Buffer/solution recipe 
Adhesion buffer RPMI without phenol red supplemented with 1.3 
mM calcium chloride, 10 mM HEPES and 1 mM 
magnesium chloride, pH 7.4 
Antibody 
staining buffer 
for flow 
cytometry 
20 ml 1x PBS, 4 ml 10 BSA, 400 µl mouse serum, 
400 µl rabbit serum, 400 µl human serum 
Antigen retrieval 
solution 
70 ml aqua dest. with 20 mM citric acid, 83 mM 
sodium citrate supplemented with 0.5% Tween20 
Blocking 
solution 
6 ml PBS with 1% BSA and 3 drops horse serum 
Digestion 
medium 
RPMI with phenol red and 1% fetal calf serum, pH 
7.4 
MACS buffer 1x PBS with 0.5% BSA and 3 mM EDTA 
Red blood cell 
lysis buffer 
150 mM ammonium chloride, 10 mM potassium 
bicarbonate, 0.1 mM EDTA diNa, pH 7.4 
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2.2.  Cell isolation 
 
Human leukocytes were isolated as described below and cultured in adhesion 
buffer. Blood was drawn from healthy volunteers into 9 ml K3E EDTA S-Monovette® 
(Sarstedt) tubes using a 21G Safety Multifly® needle (Sarstedt). 
 
2.2.1. Isolation of human neutrophils  
 
Fresh drawn venous blood (5 ml) was layered on 5 ml PolymorphprepTM (37°C, Axis-
Shield) in a 15 ml sterile centrifuge tube (Sarstedt). A density gradient was created 
by centrifuging the Polymorphprepr: Blood during 30 min at 500 g ( acceleration: 9, 
deceleration: 0, Heraeus Megafuge 16, Thermo Fisher). 
 
After centrifugation, the PolymorphprepTM gradient shows three cell layers; 
an upper ring of mononuclear cells, the second ring of polymorphonuclear cells, and 
a third sedimented erythrocyte (Figure 12). The PolymorphprepTM contains a 
polysaccharide that causes aggregation of erythrocytes, leading to sedimentation of 
these cells [176].  
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Figure 12: Schematic diagram of polymorphonuclear cell isolation. 
Purification of polymorphonuclear cells using PolymorphprepTM. Freshly drawn blood is layered on 
top of PolymorphprepTM 1:1 and centrifuged at 500 xg for 30 min. After centrifugation erythrocytes 
are sedimented. Above the erythrocytes are polymorphonuclear cells located followed by 
mononuclear cells and plasma. 
 
The second ring contains polymorphnucelar cells, was collected into a 50 ml 
centrifuge tube (Sarstedt) and filled up with room temperature (RT) 1x PBS (Gibco), 
and washed once at 300 g for 5 min. The supernatant was removed, and the 
remaining erythrocytes were lysed with 3 ml of lysis buffer for 3 min at RT. Before 
repeating the centrifugation step, lysis was stopped by filling up the 50 ml centrifuge 
tube with 1x PBS. The washed cell pellet was resuspended in adhesion buffer and 
kept on ice for 30 min. The cell purity was verified by flow cytometry as described 
later and account for between 82.4 and 97.9% (Figure 13). 
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Figure 13: Flow cytometry of isolated neutrophils. 
Neutrophils were isolated using PolymorphprepTM gradient centrifugation. Neutrophil purity accounts 
for 82.4 and 97.9%. 
 
2.2.2. Isolation of human monocytes 
 
PolymorphprepTM gradient isolation (see 2.2.1.) of leukocytes was also used to 
collect mononuclear cells followed by the isolation with the monocyte isolation kit II 
(MACS Miltenyi Biotec). The mononuclear cell ring was collected from the 
PolymorphprepTM gradient and washed three times with 1x PBS (Gibco) 
supplemented with 0.5 mM EDTA (Karl Roth), centrifugation for 5 min at 300 g. In 
the next step, the cell pellet was resuspended in MACS buffer, and isolated 
according to the user manual. Briefly, monocytes were negatively selected by 
adding a biotin-antibody mix to label all leukocytes except for monocytes and 
incubated on ice for 10 min. After incubation anti-biotin magnetic beads were added 
to the cells and incubated on ice for another 15 min. Cells were then washed with 
MACS buffer and centrifuged at 300 g for 5 min. The cell pellet was resuspended in 
MACS buffer and applied to a LS column (MACS Milenyi) attached to a magnet. The 
flow-through, containing monocytes were collected in a 50 ml tube (Sarstedt). The 
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purity was verified by flow cytometry counterstaining the cells with CD14-FITC 
antibodies. 
 
2.3. NET- formation  
 
Neutrophils were isolated via PolymorphprepTM gradient (see 2.2.1.) and adjusted 
to a final cell concentration of 4x106/ml by counting the cell number in a Neubauer 
counting chamber (Carl Roth) and diluted in adhesion buffer to the intended cell 
concentration. 200.000 cells/well were seeded in 96-well flat-bottom plate (Falcon 
Corning) and left to settle down for 15 min at 37°C and 5% CO2. The non-adherent 
cells were washed off with 100 µl 1x PBS (Gibco). Afterward, 50 µl of 25 µM calcium 
ionophore A23187 (Sigma Aldrich) diluted in adhesion buffer was added to 
neutrophils and incubated for 1 h at 37°C and 5% CO2 to stimulate the cells for NET-
release. 
 
2.4. In vitro assays 
 
To assess monocyte adhesion to NETs, adhesion assays under static and flow 
conditions were performed. 
 
2.4.1. Static adhesion assay 
 
Adhesion of monocytes to NETs was studied under static conditions. Isolated 
monocytes (see 2.2.2.) were stained with 3 µM of CellTrace™ calcein violet AM 
(Thermo Fisher Scientific) according to the instruction manual for 30 min at 37°C 
and 5% CO2. Monocytes were then washed and 50.000 cells/well were seeded to 
washed wells containing either neutrophils or netting neutrophils (see 2.3.) for 15 
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min at 37°C and 5% CO2 (Figure 14). Non-adherent monocytes were washed off 
three times using 100 µl 1x PBS (Gibco). Adherent monocytes were measured in a 
microplate reader (Tecan infinite™ 200 pro) with extinction 400 nm and emission 
452 nm as a bottom read with multiple reads 3x3 and gain 50. Neutrophil 
extracellular traps were visualized by counterstaining extracellular DNA with 
SYTOX™ Green Nucleic Acid Stain (5 µM, Invitrogen) in a Leica microscope Dmi8 
microscope. 
 
 
Figure 14: Scheme of static adhesion assay.  
200.000 neutrophils/well were seeded into a 96-well plate and settled down for 15 min at 37°C and 
5% CO2. The non-adherent cells were washed off with 100 µl 1x PBS. Afterward, 50 µl of 25 µM 
calcium ionophore A23187 diluted in adhesion buffer was added to neutrophils and incubated for 1 
h at 37°C and 5% CO2 for NET -formation. Wells were washed and CellTrace™ calcein violet AM 
stained monocytes (50000 cells) were added on top of the NETs for 15 min and washed off again. 
The adherent monocytes were analyzed by fluorescent intensity measurements.  
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2.4.2. Flow adhesion assay 
 
Adhesion of monocytes to NETs under flow condition was studied by using a 6 
channel µ-slide VI 0.4 ibiTreat (Ibidi). Isolated neutrophils (1x105) (see 2.2.1.) were 
left to adhere in the flow chamber channel either with or without 25 µM calcium 
ionophore A23187 for 60 min (Figure 15). The channel was washed under applied 
flow (0.5 dynes/ cm2) using a pump (PHD ULTRA syringe pump, Harvard Apparatus) 
for 3 min with 1x PBS. Afterward, the remaining buffer was removed from the 
reservoir 1 and 100 µl monocytes (see 2.2.2.) were added to the system. The flow 
was applied (0.5 dynes/ cm2) for another 3 min, followed by a washing step with 1x 
PBS. Cells were fixed with 4% paraformaldehyde (PFA) for 5 min and 3 fields of 
interest were acquired with a Leica microscope Dmi8 to quantify adhesive 
monocytes using free available software ImageJ (National Institutes of Health). 
Neutrophil extracellular traps were visualized by counterstaining extracellular DNA 
with SYTOX™ Green Nucleic Acid Stain (5 µM, Invitrogen). 
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Figure 15: Scheme of flow adhesion assay.  
Isolated neutrophils (1x105) applied through reservoir 1 with a 2 ml syringe and left for adhesion for 
15 min. Afterward 25 µM calcium ionophore A23187 was added under flow and cells were incubated 
for 30 min to cause NET-formation (green). The channel was washed under applied flow (0.5 dynes/ 
cm2) by a pump (PHD ULTRA syringe pump, Harvard Apparatus) for 3 min with 1x PBS. The 
remaining buffer was removed from the reservoir 1 and 100 µl monocytes (red) were added to the 
system. Flow was applied (0.5 dyne/ cm2) for 3 min. Reservoir 1 was emptied and refilled with 1x 
PBS (Gibco) to wash off the non-adherent cells. Three pictures per channel were taken and analyzed 
by using ImageJ (National Institutes of Health). 
 
2.4.3. NET digestion 
 
The impact of neutrophil extracellular traps in monocyte adhesion was studied by 
removing the main compartment of NETs, DNA, in the static and flow adhesion 
assays. The DNA-backbone structure was digested with 10U of DNAseI (Sigma-
Aldrich) for 30 min at 37°C and 5% CO2. Before monocytes were applied to the 
system, the wells or channels were washed with 1x PBS (Gibco) to remove 
remaining DNA structures and DNAseI. The continuation of the assays was 
conducted as described in 2.4.1. or 2.4.2.. 
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2.4.4. Blocking monocyte adhesion to NETs 
under static and flow conditions 
 
Monocyte adhesion to NETs was studied under static (see 2.4.1.) and flow (see 
2.4.2.) conditions. To figure out how monocytes adhere to NETs, the monocyte 
expressed adhesion molecules, g-protein coupled receptor, toll-like receptors or 
NET-associated proteins were blocked with either antagonists or antibodies for 30 
min at 37°C and 5% CO2 as followed (Table 3): 
 
Table 3: Adhesion blocking reagents. 
To study the molecules potentially involved in monocyte adhesion to NETs, the monocyte expressed 
adhesion molecules, their g-protein coupled receptors, and TLR were antagonized. Further, NET-
associated proteins were blocked as mentioned in the table to determine its role. 
Antagonist/ 
Antibody 
Target Concentratio
n 
Company 
BX 471 CCR1 1 µM Tocris 
RS504393 CCR2 3 µM Sigma Aldrich 
SB 32437 CCR3 1 µM Tocris 
DAPTA CCR5 0.1 µM Tocris 
SB 225002 CXCR2 1 µM Tocris 
AMD CXCR4 1 µM Sigma Aldrich 
Cyclosporin H FPR-1 10 µM Tocris 
WRW4 FPR-2 10 µM Tocris 
AR-C118925xx P2Y2 10 µM Tocris 
A 740003 P2X7 0.1 µM Tocris 
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BIO1211 VLA-4 10 µM Tocris 
CU CPT 22 TLR 1-2 100 µM Tocris 
C34 TLR 4 100 µM Tocris 
Hydroxychloroquin
e sulfate 
TLR 9 100 µM Tocris 
Pertussis toxin Pan g-protein 
coupled receptor 
0,8 µg/ml Sigma Aldrich 
Rabbit polyclonal 
antibody 
Histone H2A 10 µg/ml Cell signal 
Rabbit polyclonal 
antibody 
Histone H3 10 µg/ml Abcam 
Rabbit polyclonal 
antibody 
Histone citrulline 
H3  
10 µg/ml Abcam 
Rabbit monoclonal 
antibody 
Histone H4 10 µg/ml Cell Signaling 
Rabbit polyclonal 
antibody 
Myeloperoxidas
e 
10 µg/ml Merck 
Mouse monoclonal 
antibody 
Proteinase 3 10 µg/ml R&D 
Systems 
Rabbit polyclonal 
antibody 
Neutrophil 
elastase 
10 µg/ml Biorbyt 
Rabbit polyclonal 
antibody 
Cathepsin G 10 µg/ml Biorbyt 
Rabbit polyclonal 
antibody 
LL-37 10 µg/ml Santa Cruz 
Biotechnolog
y  
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Mouse monoclonal 
antibody 
Human 
neutrophil 
peptides 1-3 
10 µg/ml Hycult 
Biotech 
LAM Non-
anticoagulant 
heparin 
50 ug/ml  
BAPTA, AM Calcium chelator 5 µM Thermo 
Fisher 
Scientfic 
CHIP H2A binding 
peptide 
200 µg/ml  
 
After incubation, cells or NETs were washed 3 times with 1x PBS (Gibco) and 
monocytes (50.000 cell/well) were added to each well containing neutrophils or 
NETs and set for adhesion as described in 4.2.1. or 4.2.2.   
 
2.5. CHIP Peptide Design 
 
Our collaboration partner used in silico computer analysis to find a protein structures 
which would bind with high specificity to the histone H2A as demonstrated by their 
previous work [124, 177, 178]. The derived histone H2A-peptide complexes were 
subsequently subjected to structural optimization and binding free energy 
calculations to predict the binding strength of peptides with histone H2A. The cyclic 
peptide CHIP (H-CEPLSEVEDYLDSSLKYNAKDTINYC-OH containing S-S bond 
between Cys at the N- and C-terminus), was selected for synthesis. 
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2.6. Biophysical assays 
 
In nature, most particles carry a certain charge in aqueous solution. Also, cells, 
including monocytes, carry a certain cell membrane surface charge, which is a 
negative surface charge [179]. To test whether charge interaction plays a role in 
monocyte adhesion to NET-resident H2A, the monocyte membrane charge was 
modified with either 200 µM cholesterol sulfate (Sigma-Aldrich) and 1 µM sulfatase 
inhibitor STX (Sigma-Aldrich) or 200 µM oleylamine (Sigma-Aldrich). Cholesterol 
sulfate is a negatively charged compound and causes an increased negative cell 
membrane charge. Whereas oleylamine is a positively charged compound that 
causes a lowering of cell membrane surface charge [124]. Both compounds 
integrate into the phospholipid bilayer of the cell membrane with the lipophilic part. 
 
2.6.1. Visualization of charge caused NET-
adhesion. 
 
Electrostatically NET -caused adhesion was studied under static conditions (see 
2.4.1.). NETs were incubated with negatively charged silica beads (1 µm, 12.5 
mg/ml, Kisker) for 15 min 37°C and 5% CO2. Non-adherend beads were washed of 
3x with 100 µl 1x PBS (Gibco). Extracellular traps were counterstained with DAPI 
(300nM) and negative charge silica fluoro beads were visualized with Leica 
microscope Dmi8. 
 
2.6.2.  Zeta-potential measurement    
 
The zeta-potential is the electrical potential of a sample in suspension and it is 
measured in millivolts (mV). This method mathematically calculates the surface 
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charge by microelectrophoresis where the charged sample moves in a cuvette as a 
response to an electric field, based on the velocity detected by light scattering. The 
mathematical calculation is based on the Smoluchowski theory [180].  
 
Leukocyte cell surface charge was measured by using a Malvern Zetasizer. 
The cuvette (DTS1070, Malvern Instruments) was filled with 600 µl 10 mM sodium 
chloride (Sigma Aldrich) and a mixture of 10 µl cell suspension (106 cells/ml) and 90 
µl 300 mM sucrose (Sigma Aldrich). Measurements were performed as triplicates at 
37°C. Each replicate with 50 runs and 150 V were applied. In between the replicate’s 
measurement was paused for 2 min. 
 
2.6.3. Atomic force microscopy 
 
Atomic force microscopy (AFM) is a high-resolution method to study force 
interaction [181]. During force measurements, AFM records force spectroscopy 
curves showing force-interaction between the probe attached to the cantilever and 
the sample in a Petri dish. The small spring-like cantilever is flexible and in this kind 
of application tipless to avoid the destruction of the cell. A laser pointing to the end 
of the cantilever enables the system to notice the motion of the cantilever via a 
detector recording the deflection of the laser (Figure 16). 
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Figure 16: Scheme of atomic force microscopy. 
Atomic force microscopy is a powerful tool to measure force interactions. The laser pointed on the 
cantilever deflects to the detector. This enables the system to detect the motion of the spring-like 
cantilever. The cell on the cantilever is probed on a sample in a dish to study force interactions. 
 
An atomic force microscope (AFM, Nano Wizard II, JPK) was used to 
investigate the mechanical properties of single living monocytes with neutrophil 
extracellular trap under temperature-controlled conditions. To probe monocytes on 
neutrophil extracellular traps, neutrophils and monocytes were isolated as 
mentioned in 2.2.1. and 2.2.2. Neutrophils (50.000 cells) were seeded on fluoro dish 
(wpi, inc) with a glass bottom and left for adherence and NET-formation as 
described in 2.1. Monocytes were captured on cantilever (MLCT-010, Bruker) 
coated with 0,1 mg/ml concavalin A (Merck) for 30 min at RT. Before fishing 
monocytes, the dish and cantilever were washed 3x with Hank’s balanced salt 
solution (Gibco) and cantilever was routinely calibrated on a clean area of the 
probing dish. Ten thousand monocytes were added to the dish and identified by 
using the Axiovert 200M microscope (Zeiss). The cantilever was manually guided 
above the monocyte and released to gently touch the monocyte. After the monocyte 
adheres to the cantilever (within 1 min), the cantilever with adherent monocyte was 
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lifted and monocyte viability was controlled by propodiumiodid (5 µl/sample, 
eBioscience) positive/negative staining (Figure 17).  
 
 
Figure 17: Cell attached to cantilever. 
The concavalin A coated cantilever was used to fish a single monocyte. After fishing, the viability 
was proved by propodiumiodid positive or negative staining. The cell in the image was additionally 
stained witch calcein AM. Scale bar 20 µm. 
 
AFM force spectroscopy was only performed with living cells. The single 
monocyte on cantilever tip was brought above a NET-structure and probed with an 
approach and retraction speed of 10 µm/s, the pulling range was set to 25 µm, the 
contact time was 0 sec and the maximal force applied to the monocyte was 200 pN. 
The monocytes were probed on an area of 10 µm resulting in ten acquired force 
curves. Before probing a next NET-structure, the monocyte was left lifted to recover 
for 10-15 min. The relevant data were analyzed by using JPK Data Processing 
software (Version spm-5.0.96) (Figure 18).  
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Figure 18: Scheme of atomic force microscopy and force curve. 
A monocyte was fished with a cantilever (MLCT-010, Bruker) coated with concavalin A (0,1 mg/ml, 
Merck). The adherent monocyte was guided on top of the neutrophil extracellular trap and probed 
with a maximal force of 200 pN. The viability of monocytes was verified by propodiumiodid (5 
µl/sample, eBioscience). The applied force curve can be divided into 4 parts. The approach of 
monocyte to NET-structure (orange), followed by the adhesion force between NETs and monocyte 
(green). The pink area reflects the detach force after monocyte adheres to NETs and the blue area 
shows the needed distance of monocyte to NET to separate them again (separation distance).  
 
2.7. In vitro monocyte incubation with Histone H2A. 
 
Monocytes isolated as described in 2.2.2. were either pre-incubated with 200 µM 
oleylamine or 200 µM ch-sulfate and 1 µM STX or left untreated. 10000 monocytes 
were left for adherence in a 24-well plate loaded with round coverslips at 37°C and 
5% CO2 for 15 min. Afterward, monocytes were incubated with 10 µg recombinant 
biotylinated-H2A (Biorbyt) for 15 min on ice. Cells were washed with cold 1x PBS 
and fixed with 4% PFA. Histone H2A was stained with streptavidin labeled with 
fluorescein isothiocyanate (FITC) and monocytes were visualized by phalloidine 
membrane staining (1/1000, Sigma-Aldrich) and incubated overnight at 4°C. Nuclei 
were counterstained with DAPI. Coverslips were transferred to a glass slide and 
mounted with prolonged antifade (Invitrogen). Samples were imaged with a Leica 
TCS SP8 microscope using a 63x oil objective. Raw images were deconvolved with 
Huygens Professional (v.16.10, Scientific Volume Imaging).  
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2.8. Animal experiments 
 
In order to confirm the findings from in vitro experiments, in vivo experiments were 
conducted in mice. 
 
2.8.1. Genotyping 
 
Mice born in our animal facility were tail biopsied for genotyping. The biopsy was 
digested in lysis buffer with 0.2 mg/ml proteinase k (Qiagen, Hilden, Germany) 
overnight at 56°C. The next day, the QIAxtractor kit (Qiagen, Hilden, Germany) was 
used to isolate the DNA according to the manufacturer’s instructions. For all genes, 
a PCR reagent mix was prepared, including 5x Green Gotaq Flexi buffer (final 
concentration 1x, Promega, Fichburg, USA), 1.5mM magnesium chloride (Sigma-
Aldrich, St. Louis, USA), 0.2 mM dNTPs (Sigma-Aldrich, St. Louis, USA), 0.5 µM 
forward primer (Sigma-Aldrich, St. Louis, USA), 0.05 U/µl GoTaq DNA polymerase 
(Sigma-Aldrich, St. Louis, USA) and 200 ng genomic DNA. The PCR mix contained 
the primer pairs of either the wildtype or mutant allele. Each experiment included 
positive and negative (water) control. The PCR product was analyzed by gel 
electrophoresis (QIAxcel Advanced System, Qiagen, Hilden, Germany). As 
following, PCR reaction programs were used: For Apoe the common forward primer 
5’GCC TAG CCG AGG GAG AGC CG 3’, wildtype reverse primer 5’TGT GAC TTG 
GGA GCT CTG CAG C 3’ and mutant reverse primer 5’GCC GCC CCG ACT GCA 
TCT 3’. The Cx3cr1 common forward primer 5’GGT TCC TAG TGG AGC TAG GG 
3’, wildtype reverse 5’TTC ACG TTC GGT CTG GTG GG 3’ and mutant reverse 
primer 5’GAT CAC TCT CGG GAT GGA CG 3’. The cycler was programmed for 5 
min 94°C, 30 sec 94°C, 30 sec 60°C, 72°C 30 sec (Apoe) or 60 sec (Cx3cr1). The 
steps two to four were repeated for 35 cycles and continued for 5 min at 72°C 
followed by a 5 min cycle at 21°C.   
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2.8.2. In vivo experiment setting. 
 
To study the impact of monocyte adhesion to NETs in the pathogenesis of 
atherosclerosis under endotoxemia, eight weeks old Apoe-/- and Cx3cr1gfp/WTApoe-
/- mice were used and fed a high-fat diet (HFD) (21% fat and 0.15% cholesterol 
(ssniff, Soest, Germany)) for four weeks to induce hypercholesterolemia and the 
development of early atherosclerotic lesions. Further, to induce endotoxemia, mice 
were injected with 1 mg/kg lipopolysaccharide (LPS) (Escherichia coli, serotype 
055:B5, Sigma Aldrich) in 1x PBS (Gibco) intraperitoneal (i.p.) four hours before the 
experiment. One group was additionally treated with BB Cl-amidine (BB Cl-A) 
(1mg/Kg BW, i.p., Cayman Chemical Company) to block NET-formation 12 h before 
and then with LPS. To investigate whether NET-resident H2A causes monocyte 
adhesion in vivo the animals receiving LPS were treated with antibody to H2A (20 
µg/mouse, Biorbyt) or with a synthesized cyclic peptide-specific binding to H2A (5 
mg/kg BW).  All mice were housed at a 12-hour light/ 12-hour dark cycle (lights on 
at 7 am, lights off at 7 pm). The used strains were bred internal. 
 
All animal experiments were approved by the local ethical committee for 
animal experimentation. 
 
2.8.3. Intravital microscopy 
 
Intravital microscopy was used to study live monocyte adhesion under endotoxemia 
conditions along the carotid artery in interaction with NETs. First of all, mice were 
anesthetized with midazolam (5,0 mg/kg), medetomidin (0,5 mg/kg) and fentanyl 
(0,05 mg/kg). After the loss of reflex, a jugular vein catheter (PE10, Becton 
Dickinson, Franklin Lakes, USA) was placed right-sided for antibody injection to 
detect Ly6G directly labelled with PE (1 μg, 1A8, Biolegend) and to apply DAPI (10 
μg, Thermo Fisher Scientific) which stains extracellular DNA. Monocytes were 
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already detectable by green fluorescence protein expressed under the control of the 
Cx3cr1 receptor in the Cx3cr1egfp/WT Apoe-/- mice. The external carotid artery was 
imaged using an Olympus BX51 microscope equipped with a Hamamatsu 9100-02 
EMCCD camera, and a 10x saline-immersion objective. The adhesion of labeled 
neutrophils and green fluorescent monocytes was imaged for 30 s. Afterward, one 
video per mouse was analyzed by counting the number of adherent myeloid cells. 
 
 
2.9.  Plasma lipid measurement 
 
Plasma cholesterol and triglyceride were measured using the CHOD-PAP kit 
(Roche) and GOP-PAP kit (Roche), according to the manufacturer’s instruction. 
 
2.10. Histology 
 
Hearts were fixed in 4% PFA for at least 24 hours and afterward transferred into 
30% sucrose (Sigma-Aldrich) for 24 hours. Subsequently, hearts were frozen in 
tissue-tek O.C.T. compound (Sakura Finetek) and 4 µm sections were collected. 
The size of atherosclerotic lesions was assessed by hematoxylin and eosin staining. 
Therefore, specimens were placed into distillate water and transferred in into 
hematoxylin for 5 min. Excess staining was washed off with tap water for 5 min. 
Followed by eosin staining for 5 min and again excess staining was removed with 
tap water. Sections were dehydrated in an ascending ethanol series and finally into 
xylene. Afterward, specimens were mounted with Roti Histo kitt II (Roth) and stored 
at room temperature. To capture images a Leica DM4000 microscope with a 20x 
objective (Leica Microsystems) and a Leica DFC 365FX camera were used and 
images were analyzed with the free available software ImageJ (National Institutes 
of Health). 
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2.11. Immunohistochemistry  
 
To quantify the neutrophil and Mac2 positive cells within the aortic roots, sections 
were stained with antibodies to Ly6G (1A8, BD Biosciences) and Mac2 (M3/38, 
biozol). Nuclei were counter-stained by DAPI (Thermo Fischer). A Leica DM4000 
microscope with a 20x objective (Leica Microsystems) and a Leica DFC 365FX 
camera was used to capture images. Sections were primed with antigen retrieval 
buffer by microwaving the samples. Afterward, the samples were left to cool down 
and placed in 1x PBS. The tissue was marked with a liquid blocking PAP pen (Dako) 
and incubated with a blocking solution for 1 hour at room temperature. Afterward, 
specimens were incubated with the respective antibodies diluted in blocking solution 
overnight at 4°C. The next day the primary antibody was washed off using 1x PBS 
and 1x PBS-Tween. The corresponding secondary antibodies were diluted in 
blocking solution and incubated for 1 hour at room temperature. Nuclei were 
counterstained with DAPI. Sections were mounted in prolonged gold antifade 
(Invitrogen). 
 
 
2.12.  Endotoxin measurement 
 
Endotoxin levels in plasma samples were measured with the Pierce Chromogenic 
Endotoxin Quant kit (Thermo Fisher Scientific) according to the user’s instruction. 
Briefly, plasma samples were diluted 1/50 in endotoxin-free water and heat-
inactivated for 15 min at 70°C. Afterward, an amebocyte lysate reagent was added 
to each sample and incubated for 30 min at 37°C. Finally, the pre-warmed 
chromogenic substrate was added to each sample, incubated for 6 min. The 
reaction was stopped by adding the provided stop solution to each sample. The 
endotoxin levels were quantified by measuring the optical density at 405 nm with 
Tecan infinite™ 200 pro. Samples were analyzed as duplicates and according to 
the standard curve plotted as endotoxin units per ml (EU/ml). 
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2.13. Cell-free DNA measurement 
 
Cell-free DNA content in plasma samples was assessed with the Quant-iT 
PicoGreen dsDNA assay (Life Technologies). PicoGreen solution was diluted 1/200 
in 1x TE buffer (supplied with the kit). Plasma samples were diluted 1/5 with 1x TE 
buffer and mixed 1:1 in a 96-well plate (Falcon corning) and incubated for 5 min at 
room temperature. Samples were quantified by fluorescence mean intensity at 480 
nm emission with Tecan infinite™ 200 pro. According to the standard curve, cell-
free DNA plasma concentration was plotted as µg/ml.  
 
2.14. NETs-ELISA 
 
The concentration of neutrophil extracellular traps in plasma samples was assessed 
by modified myeloperoxidase ELISA Kit (HK210-01, Hycult Biotech) and a cell death 
detection kit (Roche) as described elsewhere. In detail, plasma samples were added 
to the ready to use MPO-antibody coated wells and diluted 1/4 in the supplied 
dilution buffer, incubated for 60 min at room temperature. Wells were washed 4x 
with supplied washing buffer and subsequently incubated with anti-DNA antibody 
(diluted 1/40 according to the instruction). Samples were incubated for 90 min at RT 
and washed with a supplied washing buffer. Peroxidase 2,2’-azino-bis(3-
ethylbenzothiazoline-6-sulfonic acid (ABTS) was added to the wells and incubated 
for 20 min in dark. Afterward, the color change was measured via the optical density 
at 405 nm with Tecan infinite™ 200 pro reader.  
 
2.15. Flow cytometry 
 
Flow cytometry is a measurement method which is applied in biological and medical 
analysis. It dissects different cell types by applied high flow and is laser-based. 
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According to the cell size, granularity or specific antibody staining cells can be 
specifically characterized. The forward scatter light gives information about size and 
side scatter light provides information about cell granularity. To determine specific 
cell-expressed molecules direct fluorescence-labelled antibodies were used.  
 
2.15.1. Blood sample preparation for flow 
cytometry 
 
Blood was drawn retrobulbar with a capillary and collected in EDTA tube (Sarstedt). 
100 µl blood were lysed in 3 ml lysis buffer for 15 min at room temperature. Lysis 
was stopped with 3 ml of Hanks buffer. Samples were centrifuged for 5 min at 300 
g. The cell pellet was directly resuspended in 50 µl staining solution with the 
corresponding antibodies (see 2.14.5). 
 
2.15.2. Bone marrow sample preparation 
 
The bone marrow of a mouse femur was flushed with 3 ml of Hanks. The sample 
was centrifuged (5 min, 300 g) and cell the pellet was resuspended in 1 ml lysis 
buffer to lyse the remaining erythrocytes for 1 min at RT. Lysis was stopped by 
adding 1ml of Hanks buffer. After centrifugation (5 min, 300 g) cell pellet was 
resuspended in 1 ml Hanks buffer and 100 µl of the sample was used for flow 
cytometry. 
 
2.15.3. Spleen sample preparation 
 
1/3 of mouse spleen (plump end) was minced through a 30 µm filter (CellTrics, 
Partec) which was washed with 3 ml Hanks buffer. The cell suspension was 
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centrifuged for 5 min at 300 g. To lyse the erythrocytes, the cell pellet was 
resuspended in 1 ml lysis buffer and after 1 min lysis (RT) was stopped by adding 
1ml Hanks buffer. Sample was again centrifuged (5 min, 300xg) and cells were 
resuspended in 1 ml Hanks buffer. 50 µl of the cell suspension was used for flow 
cytometry. 
 
2.15.4. Aorta sample preparation 
 
To analyze the descending fat-free aorta, the aorta was minced in digestion medium 
(1,25 mg/ml liberase, Roche, 10% FCS in RPMI, gibco) and incubated for 1 h at 
37°C (water bath). The aorta was pipetted up and down every 30 min up and down 
to support the digestion. After 1h of incubation 500 µl of Hanks buffer was added 
and the sample was filtered to obtain a single cell. The cell suspension was 
centrifuged for 5 min at 300 g. Cell pellet was resuspended in RPMI with 10% FCS 
for antigen retrieval and left 30 min at 37°C and 5% CO2. After an additional 
centrifugation step (5 min, 300 g) the cell pellet was directly resuspended in antibody 
staining solution with respective antibodies (see 2.14.5).   
 
2.15.5. Cell counts 
 
Blood, bone marrow, and splenic single cells were conducted using combinations 
of antibodies specific for CD45 (A20, eBioscience), CD11b (M1/70, eBioscience), 
CD115 (AFS98, eBioscience). Before cell staining, red blood cell lysis was 
performed. Further, aorta was digested by liberase (1,25mg/ml, Roche) and single 
cells were labelled with antibodies to CD11b (M1/70   BioLegend), Ly6G (1A8, 
BioLegend), MHC II (M5/114.15.2, BD Bioscience), Gr1 (RB6-8C5, BioLegend), 
F4/80 (BM8, BioLegend), CD45 (A20, eBioscience). Cells were washed with Hanks 
buffer and directly analyzed by flow cytometry using a FACSCantoII (BD). Absolute 
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cell numbers were assessed by the use of CountBright™ absolute counting beads 
(Invitrogen). Data were analyzed with FlowJo Software (BD, 10.1 Flowjo LLC). 
 
Table 4: Analysis strategy for myeloid cells determination in different organs. 
To analyze the different cell types in the different organs the samples were stained with direct 
fluorescence antibodies to the specific proteins expressed on the cell surface. The different cells 
were determined by using the following strategies:   
Cells Blood/Bone marrow/Spleen Aorta 
Neutrophils CD45+, CD11b+, Gr1high, 
CD115- 
CD45+, CD11b+, 
MHCII-, F4/80-, Gr1high, 
Ly6G+ 
Classical monocytes CD45+, CD11b+, Gr1high, 
CD115- 
CD45+, CD11b+, 
MHCII-, F4/80-,  
Gr1high, Ly6G- 
Non-classical 
monocytes 
CD45+, CD11b+, Gr1low, 
CD115+ 
CD45+, CD11b+,  
MHCII-, F4/80- , Gr1low, 
Ly6G- 
macrophages - CD45+, CD11b+, 
MHCII+, F4/80+ 
 
 
2.16. Statistics 
 
All statistical analyses were performed using GraphPad Prism 8 software. Outliers 
were determined by Grubbs' test with α=0.05. To test normal distribution, the 
D’Agostino-Pearson omnibus test for normality was used. If normality was passed, 
data were tested by a two-tailed unpaired t-test or one-way ANOVA with Dunnet’s 
correction. The Mann-Whitney test or Kurskal-Wallis test with Dunn’s correction was 
performed when data were not normally distributed. In all used tests a 95% 
confidence interval was utilized with p<0.05 was assumed as a significant 
difference. All data are represented as mean ±SEM. 
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3. Results 
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During infections, neutrophils are highly activated to clear pathogens by 
phagocytosis or degranulation of antimicrobial proteins to the environment [13]. An 
additional defense strategy has been described in 2004 [32]. It has been shown, 
that neutrophils are able to release their genomic DNA as filament fibers to the 
environment upon infection. Those fibers are called neutrophil extracellular traps 
(NETs) and are decorated with cationic antimicrobial proteins to kill bacteria [32, 39]. 
Besides, protecting the host from invading pathogens, NETs have been described 
to be involved in many diseases if they are extensively produced or not adequately 
cleared from the host tissue. Studies show evidence of tissue damage including 
endothelial dysfunction, an initial step of atherosclerosis if NETs persist for a long 
period [67]. The highly cationic NET-associated granule proteins have been shown 
to favor leukocyte adhesion either by specific receptor interaction or even via charge 
interactions [16, 34, 92, 93]. Further, it has been shown that NETs are involved in 
lytic cell death within the plaque through charge mediated pore formation. 
Consequently, plaque vulnerability was highly increased [124]. Moreover, 
epidemiological studies reveal a dramatically increased risk to suffer from 
myocardial infarction or stroke after a respiratory infection. The risk is at its highest 
within the very first days [154, 155]. 
 
Here we hypothesize that endotoxemia-activated neutrophils cause NET-
accumulation which would lead to increased recruitment of immune cells to 
atherosclerotic lesions and result in accelerated atherosclerosis. Therefore, we 
studied atherosclerosis development under endotoxemia conditions in a well-
established Apoe-/- mouse model in early atherosclerosis to observe the effect on 
NETs in recruitment. Mice enrolled in this study received a high fat diet for 4 weeks 
to develop early atherosclerotic lesions. In addition to the high fat diet, the acute 
infection was mimicked by a single LPS challenge. 
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3.1. Neutrophil extracellular traps accelerate 
atherosclerosis during endotoxemia 
 
In initial experiments, we tested if endotoxemia causes accelerated lesion formation 
and if neutrophil extracellular traps impact on this phenomenon. 
 
3.1.1. Endotoxemia NET-formation accelerates 
atherosclerotic lesion development 
 
Endotoxins are bacteria-derived lipopolysaccharides (LPS) originating from gram-
negative bacteria. Commensal gram-negative bacteria colonize the gut and account 
for 70% of the gut microbiome [182]. However, gram-negative bacteria, commensal 
or pathogen, have LPS in the outer membrane, which is released to the environment 
upon cell growth, division, or death [183]. Circulating pyrogens activates leukocytes 
such as neutrophils and causes NET-release. Neutrophil extracellular trap-
formation is at one hand a potent immune defense strategy but on the other hand, 
it has been associated with fueled inflammation [54, 164]. Neutrophils originate from 
the bone marrow and extramedullary tissue, like spleen [184]. They are fast 
mobilized into the bloodstream to rapidly reach the site of infection. Further, under 
hypercholesterolemia conditions circulating neutrophil numbers are elevated which 
have been shown to be crucial for lesion development [98]. Epidemiological studies 
indicating infection as a potent risk factor to suffer from cardiovascular disease, 
especially within the first days after acute respiratory infection [154].  
 
We studied atherosclerosis in an early atherosclerosis model with mice 
lacking the Apoe gene and feeding them a high fat diet for four weeks (Figure 19 A). 
Endotoxemia was mimicked by intraperitoneal LPS injection (1mg/Kg BW) four 
hours before the end of the experiment. To define the role of neutrophil extracellular 
traps, one group received pharmacological NET-inhibition treatment with BB Cl-
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amidine (BB Cl-A), an inhibitor of the peptidylarginine deiminases (PAD) [185]. It 
has been shown that PAD4 plays a critical role during NET-formation which in turn 
is involved in atherosclerosis development [135]. BB Cl-A was administered 
intraperitoneal 24 hours before mice were challenged with LPS and a second BB 
Cl-A injection followed four hours before the end of the experiment with the LPS 
challenge. Mice receiving a four h LPS challenge showed a dramatically increased 
atherosclerotic lesion formation within the aortic roots compared to the control group 
(PBS). Interestingly, this effect was limited if NET-formation was pharmacologically 
blocked with BB Cl-A (Figure 19 B). Vessel size of the aortic roots was not affected 
by the induced endotoxemia as analyzed in H&E staining (Figure 19 C-D). 
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Figure 19: Endotoxemia induced NET-formation heightened atherosclerotic lesion formation. 
A) Experimental scheme; Apoe –deficient mice fed an HFD for 4 weeks. One mouse group was 
injected intraperitoneal either with PBS (ctrl) or with LPS (1mg/Kg BW) for four hours (vehicle). A 
third group was treated with a pharmacological NET- formation inhibitor (BB Cl-amidine, BB Cl-A, 
(1mg/Kg BW)) 12 h before and with LPS i.p. injection.  B) The atherosclerotic lesion size was 
assessed in the aortic root and shown as mm2.  C) Additionally, to the lesion size, the size of the 
aortic root was analyzed and expressed in mm2. D) Representative H&E images of the aortic root, 
scale bar 300 µm. Data are analyzed by one-way ANOVA with Dunnett's multiple comparisons tests; 
*p≤0.05, **p≤0.01, ***p≤0.0001. All data are presented as mean ±SEM. 
 
Endotoxemia induced by LPS reduced the number of circulating leukocytes 
(Figure 20 A, D), as well as bone marrow associated leukocytes (Figure 20 B, E) 
and splenic leukocytes (Figure 20 C, F). However, LPS is a potent activator of 
leukocytes, therefore the activation status of these leukocytes, we assessed by 
measuring the expression level of CD11b on neutrophils and monocytes from the 
circulation, bone marrow, and spleen. After four hours of LPS treatment, circulating 
neutrophils and monocytes show a significantly increased CD11b expression 
(Figure 20 A, D). Interestingly, neutrophil and monocytes from the bone marrow did 
not show a similar increase in CD11b expression as observed in circulating cells 
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(Figure 20 B, E). Further, the CD11b level of splenic neutrophils under endotoxemia 
conditions was not altered compared to splenic monocytes (Figure 20 C, F).  
 
Figure 20: Flow cytometry analysis of hematopoietic tissue and blood. 
Four hours after LPS injection blood neutrophil (A) and monocyte (D) counts are reduced compared 
to the control group. Whereas the CD11b expression is highly increased. Bone marrow leukocytes 
(B, E) and splenic leukocytes (C, F) are also reduced after LPS treatment compared to the control 
group. Splenic neutrophils show an increased CD11b expression after LPS treatment (C) but not 
bone marrow associated neutrophils (B). Monocyte CD11b expression levels are not altered in bone 
marrow or spleen in comparison to the control group (E-F). Treatment of endotoxemia mice with BB 
Cl-A did not reverse the cell count reduction either the CD11b expression level. A, E, F) Data are 
analyzed by Kruskal-Wallis test with Dunn’s post-test, and data are shown in B, C, D) are analyzed 
by one-way ANOVA with Dunnett's multiple comparisons test *p≤0.05, **p≤0.01, ***p≤0.0001. All 
data are presented as mean ±SEM. 
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3.1.2. Plaque associated cells are elevated during 
endotoxemia 
 
The first results indicate that NETs seem to play a critical role during accelerating 
atherosclerotic lesion formation because NET-formation inhibition with BB Cl-A 
abolished heightened atherosclerotic lesion formation. Dramatically lesion growth 
can be caused by various means. To determine the lesion composition, histological 
sections of the aortic roots have been stained with DAPI, to counterstain nuclei. We 
observed increased cell numbers within the lesion of endotoxemia mice compared 
to control mice. However, pharmacological treatment with BB Cl-A limited the cell 
numbers within the lesion of endotoxemia mice (Figure 21 A). Furthermore, mice 
suffering from endotoxemia showed an increased lesional neutrophil count (Figure 
21 B) and elevated numbers of lesion-associated mononuclear cells positively 
stained for Mac2 (Figure 21 C) within the aortic root. In contrast to that, endotoxemia 
mice treated with the pharmacological compound BB Cl-A did not show such an 
increase in lesion associated cells. Taken together, mice suffering from 
endotoxemia showed a larger atherosclerotic lesion with increased cellularity 
compared to control mice or pharmacological treaded animals (Figure 21 D).  
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Figure 21: Lesion associated cell increase under endotoxemia conditions. 
A-C) The lesion cellularity was overall analyzed by DAPI staining (A) and in more detail by co-staining 
cells with antibodies to Ly6G (B) and Mac2 (C). Results were expressed as mean cell numbers per 
aortic root. D) Representative immunohistochemistry image of Mac2 positive staining (grey) (DAPI, 
blue), scale bar 50 µm. Data are analyzed by Kruskal-Wallis test with Dunn’s post-test (A-B) and 
one-way ANOVA with Dunnett’s post-test (C); *p≤0.05, **p≤0.01, ***p≤0.0001. All data are presented 
as mean ±SEM. 
 
3.1.3. Neutrophil extracellular trap formation 
under endotoxemia conditions 
 
It has already been suggested that NETs play a crucial role during atherogenesis 
[135, 140].  Therefore, we tested the mice plasma samples for their DNA amount. 
By measuring the plasma samples with a PicoGreen assay, we observed an 
increased dsDNA plasma level in mice that suffered from endotoxemia compared 
to the control group or endotoxemia mice treated with NET-inhibitor BB Cl-A (Figure 
22 A). Although the plasma endotoxemia levels (EU/ml) were equally increased in 
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both groups receiving LPS with or without NET-inhibitor treatment in comparison to 
the control group (Figure 22 B). Consistent with these results, we observed a 
correlation between endotoxemia levels and NETs plasma level measured in MPO-
DNA ELISA (Figure 22 C).  
 
 
Figure 22: Endotoxemia induces NET-formation. 
A) PicoGreen analysis of cell-free dsDNA in plasma samples shown as ng/ml and (B) Plasma 
endotoxin concentration measured with amebocyte lysate assay. C) Plasma levels of neutrophil 
extracellular traps (MPO-DNA ELISA) correlating with plasma endotoxin level (pearson correlation). 
Data are analyzed by Kruskal-Wallis test with Dunn’s post-test; *p≤0.05, **p≤0.01, ***p≤0.0001. All 
data are presented as mean ±SEM. 
 
3.1.4. Neutrophil extracellular traps trigger 
myeloid cell adhesion under endotoxemia 
conditions 
 
The previous findings indicate that NETs might accelerate atherosclerosis. If 
neutrophils were able to form NETs, atherosclerotic lesions were significantly 
enlarged and show elevated cellularity in the group of mice suffering from 
endotoxemia compared to the second endotoxemia group receiving the NET-
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inhibitor or to the control group, receiving PBS. Further, endotoxemia mice show 
high plasma extracellular DNA levels which are lowered if NET-formation is 
inhibited. Thus, we assume NETs play a critical role in atherosclerotic lesion 
formation during infection. To test whether neutrophil extracellular traps are present 
in the arterial lumen and if it has any effect on leukocyte recruitment, we performed 
intravital microscopy (IVM) of the left common carotid artery.  
 
For this experimental setting, we used mice expressing a green fluorescent 
protein under the control of the Cx3cr1, a g-protein coupled receptor which is 
expressed on monocytes. In addition, these mice lack the Apoe gene and received 
HFD for four weeks. To mimic acute infection, mice were challenged four hours 
before IVM with LPS (1 mg/Kg BW). A second group received additionally to LPS 
the NET-formation inhibitor BB Cl-A (Figure 23 A). We exposed the left common 
carotid artery of Cx3cr1gfp/WT Apoe-/- mice to examine it with IVM. Mice were injected 
with a Ly6G-PE antibody and DAPI to counterstain neutrophils and extracellular 
DNA. Under endotoxemia conditions we observed extracellular DNA in fiber-shape, 
assuming this would be NET-like structures (Figure 23 B). In contrast, these NET-
like structures were strongly reduced in the control group and mice treated with 
NET-inhibitor (Figure 23 C). Interestingly, under endotoxemia conditions we 
observed an increased number of luminal adherent neutrophils by Ly6G-PE staining 
(Figure 23 D) and monocytes (Figure 23 E) if NET-structures were detectable 
compared to control mice. However, neutrophil adhesion was diminished in 
endotoxemia mice if NET-formation was inhibited.  In agreement with the increased 
adhesion observed by IVM, we detected also increased neutrophil and monocyte 
numbers of the descending aorta by flow cytometry, when mice were treated with 
LPS compared to the control group (Figure 23 F-H). The cell numbers were reduced 
when endotoxemia mice received BB Cl-A treatment. This data reveals, that 
endotoxemia might cause NET-formation, which facilitates an increased luminal 
adhesion of neutrophils and monocytes.  
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Figure 23: Endotoxemia caused NET-formation fosters luminal leukocyte adhesion.  
A) Apoe-/- Cx3cr1GFP mice were fed an HFD for 4 weeks. One experimental group was injected i.p. 
with PBS (ctrl), a second group with LPS (1mg/Kg BW) four hours (vehicle) before the end of the 
experiment. A third group received a protein arginine deiminases inhibitor (BB Cl-amidine, BB Cl-A, 
(1mg/Kg BW, i.p.)) 12 h before and with intraperitoneal LPS injection. B) Representative intravital 
microscopy images of Apoe-/- Cx3cr1GFP mice left common carotid artery, extracellular DNA is shown 
in blue (DAPI). Scale bar 50 µm. C-E) Quantification of intravital microscopy of the carotid artery. C) 
Analysis of luminal NET-like structures (extracellular DNA in fiber shape, stained in blue (DAPI)), (D) 
luminal adherent neutrophils, and (E) adherent monocytes. Data are analyzed by Kruskal-Wallis test 
with Dunn’s post-test; *p≤0.05, **p≤0.01, ***p≤0.0001. All data are presented as mean ±SEM. 
 
3.2. Monocyte adhesion to NETs in vitro 
 
The classical recruitment cascade is initiated by selectin-interaction slowing down 
circulating leukocyte followed by integrin-mediated cell arrest [186]. Beside classical 
adhesion molecules expressed on activated endothelium, also granule proteins 
released from neutrophils facilitate monocyte adhesion. It has been shown show 
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that α defensin, LL-37, and cathepsin G support monocyte adhesion [34, 92]. These 
proteins are also located in neutrophil extracellular traps [39].  
 
3.2.1. Monocyte adhesion to neutrophil 
extracellular traps in vitro 
 
The previous results have shown that neutrophil extracellular trap benefits leukocyte 
adhesion at the bifurcation site in vivo where blood flow is disturbed and caused an 
accelerated lesion formation under endotoxemia conditions in the aortic roots. Next, 
we asked how neutrophil extracellular traps facilitate luminal leukocyte adhesion. 
Therefore, we studied monocyte adhesion to NETs in vitro. First, we wanted to 
evaluate if neutrophils per se or simply neutrophil extracellular traps caused 
monocyte adhesion. Using a static adhesion and a flow adhesion assay we figured 
out a NET-dependent monocyte adhesion (Figure 24 A-B). Furthermore, the 
digestion of the NET-backbone DNA before monocyte adhesion did not lead to 
monocyte adhesion (Figure 24 A, D). However, monocyte adhesion to NETs was 
not altered by incubating monocytes with paraformaldehyde (PFA), which crosslinks 
surface proteins to prevent monocyte receptors or adhesion molecules to interact 
with neutrophils extracellular traps, neither pre-incubating monocytes with pertussis 
toxin, a pan g-protein coupled receptor antagonist, reduced monocyte adhesion 
(Figure 24 C, F). Since chemokines and cytokines guide leukocyte trafficking in 
inflammation, we additionally treated monocytes with different chemokine and 
cytokine receptor antagonists and with antagonists to formyl peptide receptor 
(Figure 24 G). Interestingly, the different treatments did not alter the adhesion ability 
of monocytes to NETs. In addition, we also blocked TLRs to test whether, if danger 
associated molecules, released during NETosis would activate monocytes for 
adhesion. However, blocking TLRs with small molecule inhibitors had no influence 
on monocyte adhesion to NETs (Figure 24 H). Moreover, we also blocked integrins 
on monocytes with antibodies to VLA4, LFA1, and MAC1 in case netting neutrophils 
or NETs themselves would cause monocyte adhesion via adhesion molecules 
(Figure 24 I). However, blocking integrins on the monocyte surface did not alter 
monocyte adhesion to NETs. Taken together, monocyte adherence to neutrophil 
extracellular traps seems to be independent on surface molecule interaction in vitro. 
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Figure 24: Neutrophil extracellular traps serve as an adhesion scaffold for monocytes in 
vitro. 
A-I) In vitro monocyte adhesion to released NETs under static or flow conditions (0.5 dynes/cm2). A, 
D) Monocytes were left for adherence to unstimulated neutrophils (ctrl), to NETs (vehicle), or 
digested NETs (DNAse). C, D, G-I). In the second experimental setting, monocytes were pretreated 
with antagonists to g-protein coupled receptor or pattern-recognition-receptors. Further, monocytes 
have been incubated with antibodies to integrins and with pan protein g-coupled receptor antagonist 
or fixative. B, E) Representative fluorescence microscopic image of monocyte (violet) adherent to 
NETs (green; neutrophils red) under static conditions ((B) scale bar 50 µM) or under flow conditions 
((E) scale bar 100 µM). Monocyte adhesion was quantified by mean fluorescence intensity (A, C, G-
I) or by cells per field (D, F). Data are analyzed by one-way ANOVA; *p≤0.05, **p≤0.01, ***p≤0.0001. 
All data are presented as mean ±SEM. 
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3.2.2. NET-resident histone H2A cause monocyte 
adhesion 
 
The previous results indicate that monocyte adhesion to NETs is independent of cell 
surface molecule interactions. Therefore, we tested if neutrophil extracellular traps 
associated proteins were able to cause monocyte adhesion. To this end, we blocked 
a variety of granule proteins, which have been detected in NETs previously [39]. 
NETs were either incubated with antibodies to α-defensin (HNP1-3), cathelicidin 
(LL-37), myeloperoxidase (MPO), proteinase 3 (PR3), neutrophil elastase (NE) or 
cathepsin G (catG). After incubating NETs with these antibodies, monocytes were 
added for adhesion. Blocking granular proteins associated with neutrophil 
extracellular trap structures did not alter monocyte adhesion (Figure 25 A). 
However, besides granule proteins, also histones are associated with NETs and 
they account for more than 70% of all proteins within the NET. Therefore, NETs 
were incubated with antibodies to core histone H2A, H3, citrullinated H3, and H4 
before adding monocytes to NETs for adhesion. Finally, monocyte adhesion was 
reduced compared to vehicle control (Figure 25 B). As visualized in confocal 
microscopy, H2A covered the NET, and monocytes binding-site is co-localized with 
histone H2A (Figure 25 C). Since we could not detect any receptor interaction we 
tested if charge interaction could cause adhesion, because histones are highly 
cationic charge. Interestingly, incubating monocytes with compounds altering the 
cell membrane surface charge caused a change in H2A binding to the cell 
membrane. Meaning, if monocytes were incubated with cholesterol sulfate, which 
adds negative charges to the cell membrane, more H2A binds to the monocytes, 
according to its high cationic character. In contrast, incubating monocytes with 
oleylamine, shifting the membrane charge of monocytes to a less negative charged 
one, caused less binding of H2A to the membrane (Figure 25 D). 
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Figure 25: Monocyte adheres to NET-associated histone H2A.  
A) Monocyte adhesion to NETs pre-incubated with antibodies to NET-associated antimicrobial 
peptides and Histones (B) analyzed by Kurskal-Wallis test with Dunn’s post-test. C) Representative 
immunofluorescence confocal microscopy image (DNA white, monocyte green, H2A red), scale bar 
10 µm. D) Representative confocal microscopy image of H2A binding monocyte in a charge 
dependent-manner, DNA blue, monocyte purple, H2A green, scale bar 5 µm. Data are analyzed by 
unpaired t-test unless otherwise stated; *p≤0.05, **p≤0.01, ***p≤0.0001. All data are presented as 
mean ±SEM. 
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3.3. Monocyte adhesion to NETs in charge-
dependent fashion in vitro 
 
Adhesion is a crucial process for cell communication as well as regulation. Classical 
adhesion cascade involves integrin, cadherin, and selectin-interactions with its 
ligands. The protein-protein interactions facilitated cell adhesion underlies van der 
Waals, hydrophobic- or electrostatic interactions. Most particles show a certain 
charge in aqueous solution. Leucocytes have on the cell membrane surface a 
carbohydrate-rich glycocalyx with an overall negative charge. Many charge 
interactions have been described in nature, e.g. bacteria are trapped by neutrophils 
extracellular traps according to charge interactions or neutrophil-derived MPO 
facilitate monocyte adhesion in a charge-dependent manner [93, 181, 187].  
 
3.3.1. Neutrophil extracellular traps attract 
monocytes electrostatically 
 
In agreement with our previous findings in vitro, the ζ-potential of monocytes 
incubated with Ch-sulfate was more negative compared to untreated cells. Further, 
monocytes incubated with oleylamine showed a less negative ζ-potential (Figure 26 
A-B). Monocytes with altered cell surface charges were added for adhesion to NETs 
under static conditions. The number of adherent monocytes was increased, if 
monocytes had an increased negative cell surface charge (Figure 26 D-E). This 
finding correlates with the binding ability of monocytes (Figure 26 C). Our data 
indicate a charge dependent monocyte adhesion to NETs. To test whether the 
charge is the crucial mediator, negative beads were incubated with NETs, 
demonstrating that charge has an impact on cell adhesion in vitro (Figure 26 F).  
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Figure 26: NETs as an electrostatic adhesion scaffold. 
A-B) Zeta Potential analysis of isolated monocytes treated with Ch-sulfate (A) or oleylamine (B). C) 
Pearson correlation of adhesion ability and zeta-potential of monocytes pre-incubated with Ch-sulfate 
or oleylamine. D-E) Mean fluorescence intensity of adherent monocytes either treated with Ch-sulfate 
(D), oleylamine (E), or left untreated. F) Representative fluorescence image of NETs (DAPI, blue) 
with nonspecific adherent negative charged FluoSpheres® (red), scale bar 10 µm. Data are analyzed 
by unpaired t-test unless otherwise stated; *p≤0.05, **p≤0.01, ***p≤0.0001. All data are presented as 
mean ±SEM. 
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3.3.2. Monocyte adhesion-strength in a charge-
dependent manner 
 
In addition to the previous experiments, further examination of monocyte adhesion 
to NETs with atomic force microscopy was performed to verify the role of charge 
interaction in monocyte-adhesion to NETs. Monocytes showing a highly negative 
membrane charge had a strengthened adhesion compared to control cells. 
Whereas, monocytes incubated with oleylamine showed a decreased adhesion 
strength measured as the area under the curve (Figure 27 A-B, D, F-H). 
Furthermore, the adhesion frequency of the differently treated monocytes was 
altered compared to control monocytes. Highly negative charged monocytes 
adhesion was 2-fold stronger compared to oleylamine treated monocytes (Figure 27 
C, E). 
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Figure 27: Monocyte-NET adhesion in a charge-dependent manner. 
A) Scheme of atomic force microscopy experiment probing monocytes on expelled NETs with 200 
pN. B, D) Area under the curve showing adhesion strength of monocytes on NETs under different 
conditions and (C, E) adhesion frequency of monocytes. F, G, H) Representative atomic force 
microscopy curves of monocytes probed on NETs treated with either Ch-sulfate or oleylamine. Data 
are analyzed by unpaired t-test unless otherwise stated; *p≤0.05, **p≤0.01, ***p≤0.0001. All data are 
presented as mean ±SEM. 
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3.4. Therapeutical neutralization of H2A prevents 
accelerated lesion development 
 
Therapeutical strategies aim to modulate neutrophil response to limit neutrophil 
caused damage [135, 188, 189]. Therefore, studies that focus on diseases caused 
by hyperactivation of neutrophils aim to inhibit neutrophil function. Nevertheless, 
insufficient neutrophil activation can also lead to poor innate immune host defense 
[190]. Consequently, therapeutical strategies modulating neutrophil response are 
challenging and might be highly depending on the timing when to modulate the 
immune response and to which extent.  
 
3.4.1. NET-associated H2A cause myeloid cell 
adhesion in vivo 
 
Our experiments revealed a dramatic increase in atherosclerotic lesion 
development upon the formation of NETs under endotoxemia conditions. We 
observed an increased luminal leukocyte adhesion if neutrophils form NETs. 
Therefore, we aimed to interrupt the heightened leukocyte adhesion in vivo. In vitro 
experiments have shown that NET-resident histone H2A mediates monocytes 
adhesion, thus we synthesized a cyclical histone 2A interference peptide (CHIP) to 
block the leukocyte interaction (Figure 28 B). Mice fed a high fat diet for 4 weeks 
received the CHIP or antibodies to H2A intravenously upon challenged with LPS 
(Figure 28 A). First, we observed no altered NET-formation in vivo in intravital 
microscopy (Figure 28 C, F) after CHIP or anti-H2a injection, but luminal adhesion 
of neutrophils and monocytes were both reduced in mice receiving CHIP and as well 
in mice receiving antibodies to H2A equality (Figure 28 D-E, G-H).  
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Figure 28: Blocking NET-resident Histone H2A limits luminal leukocyte adhesion. 
A) Experimental scheme. B) Molecular dynamic simulation of cyclical histone 2A interference peptide 
(CHIP (purple)), Histone H2A (brown), and the interaction of both. C, F) Luminal NET-like structures 
analyzed in the left common carotid artery of endotoxemia mice left either untreated or treated with 
CHIP to H2A (C) or antibodies to H2A (F). D, E, G, H) Counts of luminal adhesive neutrophils (D, G) 
and monocyte (E, H) after blocking Histone H2A under acute inflammatory conditions, analyzed by 
Mann-Whitney test. Data are analyzed by unpaired t-test unless otherwise stated; *p≤0.05, **p≤0.01, 
***p≤0.0001. All data are presented as mean ±SEM. 
 
3.4.2. Pharmacological intervention 
 
CHIP limited luminal leukocyte adhesion under endotoxemia conditions. Further, we 
studied monocyte adhesion properties if NETs were incubated with CHIP. In static 
adhesion assay, fewer monocytes adhere to NETs if NETs have been pre-incubated 
with CHIP (Figure 29 A) and as well the adhesion strength was significantly reduced 
in the atomic force microscopy (Figure 29 B-D). Interestingly, mice treated with CHIP 
neutralized the effect of accelerated atherosclerosis under endotoxemia conditions 
(Figure 29 E). Additionally, lesion associated neutrophils and Mac2 positive 
mononuclear cells were reduced (Figure 29 F-H).  
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Figure 29: Therapeutically intervention of NET-resident Histone H2A attracted monocytes.  
A-D) Showing experiments performed in vitro and E-H) were ran in vivo. A) Pharmacological 
interruption of NET-resident H2A monocyte binding in vitro measured as mean fluorescence 
intensity. B) Binding strength analyzed in atomic force microscopy after NETs treated with CHIP. C-
D) representative atomic force microscopy curves representing adhesion strength. E) Atherosclerotic 
lesion size in aortic roots measured in mm2. F-G) Plaque associated neutrophils (Ly6G+ cells) (F) 
and Mac2 positive cells (Mac2+ cells) (G) per aortic root. H) Representative immunofluorescence 
images showing plaque-associated Mac2 positive cells (grey) and nuclei (DAPI, blue), scale bar 50 
µm. Data are analyzed by Mann-Whitney test (A) or by unpaired t-test (B, E-G); *p≤0.05, **p≤0.01, 
***p≤0.0001. All data are resented as mean ±SEM. 
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4. Summary
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The results presented here provide evidence that endotoxemia- activated 
neutrophils cause accumulation of NETs and favor leukocyte adhesion, which in 
turn causes accelerated atherosclerosis. During infections, bacteria release LPS, 
which is a potent activator of circulating immune cells including neutrophils. 
Activated neutrophils foster inflammation through expelled chromatin (NETs). 
Neutrophil extracellular traps contain cationic granule proteins which have been 
shown to support monocyte recruitment to endothelial cells either in a receptor-
dependent manner or even charge mediated [16, 34, 92, 93]. But the most abundant 
protein within NET-structure is histones. They account for 70% of NET-associated 
proteins [39]. Recently it has been shown that these NET-borne histones cause in 
a charge dependent fashion plaque vulnerability [124]. Additionally, NETs have 
been associated with endothelial dysfunction and enhanced atheroprogression 
[140, 185]. Furthermore, epidemiological studies show a highly increased risk to 
suffer from CVD after infection within the first three days [154].  
 
The present study shows the first-time enhanced NET-mediated leukocyte 
adhesion in acute infection and demonstrates the link between endotoxemia-
induced NET-release and accelerated lesion formation. Based on in vivo 
experiments we detect luminal NET-like structure, which increases leukocyte 
adhesion at branch points, and we observe heightened lesion formation within four 
hours, which could be diminished by inhibiting NET-formation. Neutrophil 
extracellular traps are decorated with cationic proteins as granule proteins and 
histones. Surprisingly, monocyte adhesion to NETs was receptor-independent and 
further independent on the granule proteins, which have been described to facilitate 
leukocyte adhesion. Even so, if histones were blocked the monocyte adhesion was 
significantly decreased. Further experiments showed that monocyte adheres to 
NETs in a charge-dependent manner. Strikingly, therapeutically blocking H2A 
neutralized accelerated NET-formation under endotoxemia conditions. 
Nonetheless, limiting overall leukocyte adhesion or NET-formation during infection 
might lead to insufficient immune response. Therapeutic strategies aiming for a 
specific intervention could be a promising preventive strategy to reduce 
cardiovascular events.  
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5. Discussion 
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5.1. Endotoxemia accelerates atherosclerosis 
 
Atherosclerosis is a chronic inflammatory disease, which develops over decades. 
It’s characteristic lipid deposition and modification in the intima fosters inflammation 
[104]. Multiple risk factors for atherosclerosis have already been described, they 
include smoking as a source of LPS, hypercholesterolemia, or hyperglycemia [143, 
191, 192]. The Burneck study showed the impact of endotoxemia on the 
pathogenesis of atherosclerosis. The authors demonstrated elevated circulating 
endotoxin levels in patients with chronic infection and suggest gram-negative 
derived endotoxin levels as a predictor of increased atherosclerosis risk [193]. 
Additionally,  epidemiological studies indicate an increased risk to suffer from CVD 
within the first three days after a respiratory infection [154, 155]. During infection, 
neutrophils are classically viewed as the first cells to be recruited and to build the 
first line of defense. Upon activation, neutrophils adhere to endothelial cells and 
transmigrate to the site of infection [13]. Additionally, pathogen-associated 
molecular pattern molecules (PAMPs) as LPS cause neutrophil extracellular trap 
formation, which in turn leads to endothelial dysfunction [135, 194]. LPS and NETs 
are known factors to favor atherosclerosis. The underlying mechanism of 
accelerates pathogenies of atherosclerosis is unknown. Therefore, the present 
study describes for the first time, a mechanism causing heightened lesion formation 
under endotoxemia conditions.  
 
First, we observed highly increased atherosclerotic lesion formation under 
endotoxemia conditions, which was neutralized when neutrophil extracellular trap 
formation was limited. Knight et al. ascribe NETs a critical role during 
atherosclerosis. They described limited atherosclerotic lesion formation when the 
enzyme peptidylarginine deiminase (PAD) in Apoe-/- mice was pharmacologically 
inhibited with Cl-amidine [135]. The study showed besides smaller lesion size, also 
fewer macrophages within the lesion as well as reduced lesion-associated 
neutrophils when mice were treated with Cl-amidine. Under endotoxemia 
conditions, we observe an increased atherosclerotic lesion size with increased 
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neutrophils and monocytes in the intima. Acute infections caused a decrease of 
circulating myeloid cells, bone marrow, and splenic myeloid cells while the CD11b 
expression of circulating neutrophils and monocytes was highly increased, 
indicating myeloid cells were activated for adhesion, which is independent on 
pharmacological inhibition with BB Cl-amidine. Since we observed a massive 
reduction of splenic, bone marrow, and circulating leukocytes under endotoxemia 
condition independent on Cl-amidine treatment one can speculate that NET-effect 
could be rather local and might not play an important role in global leukocyte 
adhesion, which needs to be further investigated. Nevertheless, this observation 
point to a crucial role for neutrophil extracellular traps during atheroprogression in 
acute infection. Additionally, we detected increased plasma NET-level with a 
PicoGreen assay as well as with NET-ELISA, which was diminished after treating 
mice with BB Cl-amidine. Further, we observed luminal NET-like structures within 
the murine carotid artery, which fostered neutrophil and monocyte adhesion.  
  
5.2. Neutrophil extracellular traps launch monocyte 
adhesion 
 
A crucial step during atherogenesis is myeloid cell recruitment which is regulated by 
adhesion molecules expression on endothelial cells. Leukocyte adhesion is tightly 
regulated by chemokines and integrins expression [11]. Elevated neutrophil counts 
benefit atherogenesis while neutropenia reduces atherosclerosis [98]. Interestingly, 
the importance of neutrophils during atherogenesis was long neglected due to their 
abundance within the atherosclerotic lesion [118]. Nevertheless, footprints of 
neutrophils have been detected as a reliable biomarker of atherosclerosis outcome 
[195, 196]. Further, neutrophils pave the way for monocyte recruitment through 
released granule protein, which is chemotactic for monocytes and facilitates 
adhesion [16]. Besides granular protein also NETs can be released by neutrophils. 
NETs are decorated with a variety of cationic granule proteins and histones [32, 39]. 
Interestingly, neutropenia leads to insufficient monocyte recruitment [197]. Patients 
suffering from neutrophil-specific granule deficiency show defects in monocyte 
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extravasation and chemotaxis in vitro [88]. The degranulated proteins, such as α 
defensin or LL-37 are cationic charged and bind on endothelium, which in turn 
activates the endothelial cells for elevated expression of adhesion molecules 
VCAM1 and ICAM1 [16, 198, 199]. Further, secreted α defensin can form complex 
with platelet-derived CCL5 causing monocyte adhesion through monocyte 
expressed CCR5 [92]. Cathelicidin activates FPR2 on monocytes leading to 
upregulated integrin expression, which favors adhesion [35]. However, most of the 
studies describing neutrophil facilitated monocyte adhesion focus on 
microcirculation, while atherosclerosis occurs in large vessels. The physiological 
differences between micro- and macrocirculation are highly important as 
demonstrated in experiments highlighting a cathepsin G dependent monocyte 
recruitment in macrocirculation but not in the microcirculation  [34, 186]. Taken 
together, granule proteins LL-37, α defensin, and cathepsin G facilitate monocyte 
recruitment and adhesion involving g-protein coupled receptors and formyl-peptide 
receptors. Here, we studied monocyte adhesion to NETs, which was independent 
of granular proteins within the NETs. Further, we demonstrated that neither g-
protein coupled receptor nor integrins or TLRs were involved in monocyte adhesion. 
Interestingly, the most abundant proteins in the NETs are the highly cationic 
histones, which we identified in our studies to mediate monocyte adhesion. It has 
been shown that histones cause in a charge dependent manner pore formation 
within the plaque, which led to plaque vulnerability [124]. Histones foster 
inflammation through TLR2 and 4 signaling while chromatin, the NET scaffold and 
an important danger associated molecule pattern signals through TLR9 [200, 201]. 
Histones within the nucleosome complex are not supposed to be cytotoxic 
compared to histones released from NETs after DNA digestion [124, 202, 203].  
 
5.3. NETs facilitate adhesion in a charge-dependent 
manner 
 
Charge interaction can be found during the innate immune response to support cell-
cell interplay, but charge can also prevent uncontrolled cell recruitment. Endothelial 
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cells are covered with glycocalyx whose main components are glycosaminoglycon, 
heparan sulfate, and chondroitin sulfate giving cells a typical negative membrane 
charge. The 500 nm thick endothelial glycocalyx prevents under steady-state 
uncontrolled leukocyte adhesion [204]. During infection or inflammation, the 
glycocalyx is shed showing adhesion molecules, allowing leukocyte to adhere and 
transmigrate [205, 206]. Among the adherent leukocyte to endothelial cells during 
inflammation, neutrophils are the first cells to be recruited. They release granule 
proteins, which have antimicrobial activity and have been shown to favor myeloid 
cell adhesion [16]. Interestingly, myeloperoxidase is one of the released proteins by 
neutrophils upon activation, which causes myeloid cell adhesion in a charge-
dependent manner [93]. Granule proteins show high cationic charges resulting from 
the arginine-rich composition [198, 199]. Electrostatically cell adhesion has also 
been shown for elastase and proteinase 3, which are also part of neutrophil 
extracellular traps [198, 199].  
 
Besides granule proteins, also histone H2A, H2B, H3, and H4 decorate 
neutrophil extracellular traps. Histones form a core that is wrapped with 147 base 
pairs of DNA in the nucleosome. The linker histones H1 und H5 connect the 
nucleosomes and regulate chromatin compactness. Histones are rich amino acid 
lysin and arginine, both highly cationic giving histones the highly positive charged 
character [207]. However, leukocytes show a negative membrane charge due to 
their glycocalyx [179]. In our experiments, we measured the monocyte surface 
charge with zetaziser and manipulated the monocytes' charge. Our experiments 
highlighted a charge dependent monocyte adhesion to neutrophil extracellular traps. 
Further, cell-cell interaction can be measured with atomic force microscopy. So far, 
cell charge interaction has been studied with cells adhering to well defined charged 
surfaces or cells [208, 209]. We measure here the first time the force interaction 
between neutrophil extracellular traps and viable monocytes indicating that 
monocyte adhesion to neutrophil extracellular traps is charge dependent. 
Interestingly, charge interaction is an unspecific mechanism make it challenging to 
study charge interaction in vivo. Nevertheless, the group of Nicolaes treated septic 
mice, where cell free histones cause cytotoxicity, with heparin a highly anionic 
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charge molecule, neutralized cationic charge pointing to charge interaction in vivo 
[210].  
 
5.4. Therapeutic implication 
 
Atherosclerosis develops over decades and is diagnosed at a clinical stage. The 
chronic inflammatory disease leads to CVD causing approximately one-third of the 
death worldwide [211]. Therefore, the prevention of atherosclerosis is an important 
research field with growing interest. Limitation of the inflammatory processes during 
atherogenesis can be driven by cholesterol efflux, neutralizing cytokines, promoting 
leukocyte egress, or inhibiting leukocyte recruitment [111, 212-215]. Nowadays, the 
treatment of atherogenesis targets well-known atherosclerotic risk factors as 
hypertension and hypercholesterolemia. Nevertheless, statins treatment or high 
blood pressure regulating drugs (beta-blocker) do not aim to limit chronic 
inflammation. But atherosclerosis is nowadays well described as a chronic 
inflammatory disease, were uncontrolled leukocyte recruitment fuel inflammation 
[97]. Targeting the imbalanced inflammatory response in combination with the 
golden standard of cardiovascular disease therapy can be an improvement in the 
treatment of atherosclerosis. Studies that focused on anti-inflammatory strategies 
showed a beneficial immune-modulating effect using cytokine-inhibitors [111]. 
Therefore, disruption of leukocyte recruitment into lesions is believed to be a potent 
therapeutic target [171, 172]. Thus, blockage of CCL5, which controlled adhesion of 
monocytes among others shows a reduced atherosclerotic progression in mice, 
consequently showing reduced macrophage numbers in atherosclerotic plaque and 
smaller lesion size [172]. Further, inhibition of chemokine CCL2, CCL5, and CX3CL1 
reduced leukocyte recruitment and improve lesion stability [171]. Nevertheless, the 
impairment of overall leukocyte recruitment might lead to weakened immune 
defense, as observed in the CANTOS-study. The specific neutralization of pro-
inflammatory cytokine IL-1ß leads to a higher incidence to suffer from infection and 
sepsis [216]. 
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 However, monocytes have been acknowledged to contribute to 
atherosclerotic lesion formation, progression, and destabilization [217]. Additionally, 
insights from human atherosclerotic lesions and mouse studies highlighting 
neutrophils to accelerate atherosclerotic lesion development [218-220]. Neutrophils 
assist monocyte adhesion by releasing granule proteins like LL-37 or cathepsin G 
[16]. Additionally, neutrophil-derived myeloperoxidase has been shown to favor 
leukocyte adherence to endothelial cells in a charge dependent fashion [93]. 
Nevertheless, LL-37, cathepsin G, and MPO are also neutrophil extracellular trap 
associated proteins [39]. NETs are released to limit infection but have also been 
shown to fuel chronic inflammation as atherosclerosis. Studies using mice deficient 
in serine protease, neutrophil elastase or PAD4, show a critical role of NETs during 
atherosclerosis [55, 140]. These data indicating a potential role of neutrophil 
extracellular traps during atherogenesis. The most abundant proteins within the 
NETs are histones, which have been shown to trigger plaque vulnerability. 
Nevertheless, blocking histone was shown to limit plaque vulnerability. Strikingly, in 
sepsis study, the neutralization of histones during sepsis reduces organ damage 
[124, 210]. We found NET-resident histone H2A facilitates monocyte adhesion 
leading to heightened lesion formation during endotoxemia, which was limited after 
H2A blocking in vivo. These results highlight an anti-histone therapy as a potential 
treatment strategy. Nevertheless, the total blockage of neutrophil extracellular traps 
might have side effects as insufficient immune response due to its antimicrobial 
activity in tissue as well as in circulation, which has to be further investigated. 
Additionally, the time of treatment might also be an important question to answer, 
since leukocyte recruitment shows time-dependent rhythmicity [91]. Therapies that 
specifically reduce leukocyte recruitment in synergy with nowadays-used 
cholesterol-lowering therapies could be a useful strategy to improve the disease 
outcome in advanced atherosclerosis.
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6.1. Outlook 
 
Many studies highlight the pro-inflammatory role of NETs during the onset of 
diseases as atherosclerosis. Epidemiological studies highlight a causal link between 
infection and CVD. But the underlying mechanism remains so far unclear. To find 
new therapeutic strategies it is important to understand the molecular and cellular 
mechanisms of atherosclerosis. We describe here the mechanism of endotoxemia 
accelerated atherosclerosis. We observe that monocyte adheres electrostatically to 
NET-resident histone H2A, which was reversed by our synthesized histone H2A 
blocking peptide. Nonetheless, our study reveals further questions for future 
research. 
 
Here we observe a 50% increased atherosclerotic lesion size after 4 hours of 
LPS challenge. We show, during acute infection that neutrophil extracellular traps 
play a critical role to cause a heightened increased lesion formation. So, the 
question arises if this observed effect remains after a long period or the effect can 
be reversed. Further, the crosstalk of NETs with other cells like the endothelial cells 
or monocytes has to be studied in more detail. It has been shown that neutrophil 
harbor miRNA, which might be also expelled to the environment within the NETs 
[221]. This miRNA could alter the phenotype of monocytes and activate them for 
chemokine release which fuels inflammation. These open questions might give a 
hint of why we observe a quite fast doubling of the atherosclerotic lesion size. 
Additionally, the effect of NET-mediated leukocyte adhesion during acute infection 
on advanced atherosclerotic lesion has to be studied in more detail, since the 
consequences of atherosclerosis as myocardial infarction or stroke occur in the late 
stage of atherosclerosis [104]. 
 
 Our study explores accelerated atherosclerosis with a single LPS challenge 
in young mice. We observed luminal NET-release within four hours. To translate our 
findings into human more detailed studies are necessary. So far it has been 
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described that neutrophils of old individuals show impaired phagocytosis and 
decreased respiratory burst [222, 223]. The ability of neutrophils of elderly 
individuals to form neutrophil extracellular traps has not so far studied in detail, but 
due to the decreased bactericidal activity of these neutrophils, it has been suggested 
that NET-formation is limited [224, 225]. The proof of principle with neutrophils from 
elderly individuals is necessary to better understand pathomechanism in humans. 
 
 During our investigation we designed a histone-based therapeutic treatment 
strategy, which was applied after the LPS challenge, mimicking an acute infection. 
It has been shown that insufficient function neutrophils impair pathogen clearance 
causing a worse outcome for patients. Here we block histone H2A to prevent 
leukocyte adhesion, which might have an impact on pathogen clearance but also 
limited pathogen entrapment can be a consequence of blocking cationic proteins 
within the NET. Further, it has to be considered that different NET-formation 
stimulus leads to different NET-formation pathway and might also result in different 
NET-protein composition. Besides NET-composition, also the site of NET-formation 
may play a major role. Here we observe a massive increase in leukocyte adhesion 
to arterial vessels, which was reduced after H2A blocking. However, this effect could 
differ in venous circulation as described for cathepsin G, which favors leukocyte 
recruitment in the artery but not in veins [34].  
 
 Taken together, future investigations focusing on pro-inflammatory 
processes during atherogenesis will mild atherosclerosis outcome by uncovering 
pro-inflammatory mechanisms improving treatment for CVD. 
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